grepcent / static financial knowledge base

PHOTRONICS INC (PLAB)

CIK: 0000810136. SIC: 3674 Semiconductors & Related Devices. Latest 10-K as of: 2025-12-17.

SIC breadcrumb: Manufacturing > Electronic And Other Electrical Equipment And Components, Except Computer Equipment > SIC 3674 Semiconductors & Related Devices

SEC company page: https://www.sec.gov/edgar/browse/?CIK=810136. Latest filing source: 0001140361-25-045801.

Informational only - descriptive public-record data, not investment advice.

Business

Read PLAB's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read PLAB's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue849,294,000USD20252025-12-17
Net income136,405,000USD20252025-12-17
Assets1,804,534,000USD20252025-12-17

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2025-12-17. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000810136.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2016201720182019202020212022202320242025
Revenue450,678,000535,276,000550,660,000609,691,000663,761,000824,549,000892,076,000866,946,000849,294,000
Net income46,200,00013,130,00042,055,00029,793,00033,820,00055,449,000118,786,000125,485,000130,688,000136,405,000
Operating income52,475,00031,868,00065,627,00052,121,00063,928,00094,554,000211,866,000253,050,000221,518,000208,161,000
Gross profit118,706,00091,315,000131,503,000120,841,000134,654,000167,044,000294,213,000336,162,000315,946,000299,830,000
Diluted EPS0.640.190.590.440.520.891.942.032.092.28
Operating cash flow122,137,00096,833,000130,567,00068,386,000143,046,000150,772,000275,187,000302,176,000261,444,000247,798,000
Capital expenditures50,147,00091,965,00092,585,000178,375,00070,815,000109,099,000112,338,000131,295,000130,942,000188,137,000
Share buybacks0.000.0023,111,00021,696,00034,394,00048,249,0002,522,0000.000.0097,422,000
Assets987,988,0001,020,794,0001,110,009,0001,118,665,0001,188,182,0001,294,202,0001,315,830,0001,526,221,0001,712,059,0001,804,534,000
Liabilities162,514,000155,499,000205,440,000207,573,000225,916,000293,640,000253,741,000250,612,000231,300,000207,227,000
Stockholders' equity710,363,000744,564,000759,671,000769,892,000804,962,000823,692,000831,527,000975,008,0001,120,864,0001,173,589,000
Cash and cash equivalents314,074,000308,021,000329,277,000206,530,000278,665,000276,670,000319,680,000499,292,000598,485,000492,256,000
Free cash flow71,990,0004,868,00037,982,000-109,989,00072,231,00041,673,000162,849,000170,881,000130,502,00059,661,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2016201720182019202020212022202320242025
Net margin2.91%7.86%5.41%5.55%8.35%14.41%14.07%15.07%16.06%
Operating margin7.07%12.26%9.47%10.49%14.25%25.69%28.37%25.55%24.51%
Return on equity6.50%1.76%5.54%3.87%4.20%6.73%14.29%12.87%11.66%11.62%
Return on assets4.68%1.29%3.79%2.66%2.85%4.28%9.03%8.22%7.63%7.56%
Liabilities / equity0.230.210.270.270.280.360.310.260.210.18
Current ratio5.435.492.632.813.503.133.334.245.075.37

Industry Peer Context

Each number-line places PLAB against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

PLAB Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 59.PLAB Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 59.59 SIC peersMin -101.6%Median 4.9%Max 57.7%PLAB 16.1%

Operating margin peer context

PLAB Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.PLAB Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.58 SIC peersMin -148.7%Median 3.7%Max 60.5%PLAB 24.5%

ROE peer context

PLAB ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.PLAB ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.58 SIC peersMin -146.9%Median 4.3%Max 76.3%PLAB 11.6%

ROA peer context

PLAB ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 61.PLAB ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 61.61 SIC peersMin -95.6%Median 1.7%Max 58.1%PLAB 7.6%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Income statement bridge from reported figures

PLAB FY2025 income statement bridge from reported figures.PLAB FY2025 income statement bridge from reported figures.PLAB income bridgeFY2025: revenue to net incomeSource: SEC companyfacts FY2025.Income statement bridgeReported amount$0.0B$500.0M$1.0B$849.3MRevenue-$549.5MCost$299.8MGross-$91.7MOpEx$208.2MOperating-$71.8MOther/tax$136.4MNet income

Figure provenance: SEC companyfacts FY 2025. Revenue: accession 0001140361-25-045801; concept RevenueFromContractWithCustomerExcludingAssessedTax; source concepts us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Gross profit: accession 0001140361-25-045801; concept GrossProfit; source concepts us-gaap:GrossProfit | Operating income: accession 0001140361-25-045801; concept OperatingIncomeLoss; source concepts us-gaap:OperatingIncomeLoss | Net income: accession 0001140361-25-045801; concept NetIncomeLoss; source concepts us-gaap:NetIncomeLoss

Free cash flow = operating cash flow - capital expenditures

PLAB FY2025 free cash flow bridge from reported figures.PLAB FY2025 free cash flow bridge from reported figures.PLAB free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$247.8MOperating cash flow-$188.1MCapex$59.7MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001140361-25-045801; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001140361-25-045801; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001140361-25-045801; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

PLAB revenue, last 5 periods. Source: SEC companyfacts FY2025.PLAB revenue, last 5 periods. Source: SEC companyfacts FY2025.PLAB RevenueLatest point: FY2025 = $849.3MSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$500.0M$1.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

PLAB net income, last 5 periods. Source: SEC companyfacts FY2025.PLAB net income, last 5 periods. Source: SEC companyfacts FY2025.PLAB Net incomeLatest point: FY2025 = $136.4MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

PLAB operating income, last 5 periods. Source: SEC companyfacts FY2025.PLAB operating income, last 5 periods. Source: SEC companyfacts FY2025.PLAB Operating incomeLatest point: FY2025 = $208.2MSource: SEC companyfacts FY2025.Fiscal yearOperating income$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

PLAB gross profit, last 5 periods. Source: SEC companyfacts FY2025.PLAB gross profit, last 5 periods. Source: SEC companyfacts FY2025.PLAB Gross profitLatest point: FY2025 = $299.8MSource: SEC companyfacts FY2025.Fiscal yearGross profit$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: GrossProfit. Source concepts: us-gaap:GrossProfit.

PLAB diluted eps, last 5 periods. Source: SEC companyfacts FY2025.PLAB diluted eps, last 5 periods. Source: SEC companyfacts FY2025.PLAB Diluted EPSLatest point: FY2025 = $2.28/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$2.00/share$4.00/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

PLAB operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.PLAB operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.PLAB Operating cash flowLatest point: FY2025 = $247.8MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

PLAB capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.PLAB capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.PLAB Capital expendituresLatest point: FY2025 = $188.1MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

PLAB share buybacks, last 5 periods. Source: SEC companyfacts FY2025.PLAB share buybacks, last 5 periods. Source: SEC companyfacts FY2025.PLAB Share buybacksLatest point: FY2025 = $97.4MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

PLAB assets, last 5 periods. Source: SEC companyfacts FY2025.PLAB assets, last 5 periods. Source: SEC companyfacts FY2025.PLAB AssetsLatest point: FY2025 = $1.8BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: Assets. Source concepts: us-gaap:Assets.

PLAB liabilities, last 5 periods. Source: SEC companyfacts FY2025.PLAB liabilities, last 5 periods. Source: SEC companyfacts FY2025.PLAB LiabilitiesLatest point: FY2025 = $207.2MSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

PLAB stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.PLAB stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.PLAB Stockholders' equityLatest point: FY2025 = $1.2BSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

PLAB cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.PLAB cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.PLAB Cash and cash equivalentsLatest point: FY2025 = $492.3MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$375.0M$750.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

PLAB free cash flow, last 5 periods. Source: SEC companyfacts FY2025.PLAB free cash flow, last 5 periods. Source: SEC companyfacts FY2025.PLAB Free cash flowLatest point: FY2025 = $59.7MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-10-31; accession 0001140361-25-045801; filed 2025-12-17. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-06-11. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000810136.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q32022-07-310.51reported discrete quarter
2023-Q12023-01-290.23reported discrete quarter
2023-Q22023-04-300.65reported discrete quarter
2023-Q32023-07-30224,206,00026,959,0000.44reported discrete quarter
2023-Q42023-10-31227,473,00044,611,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-01-28216,334,00026,180,0000.42reported discrete quarter
2024-Q22024-04-28217,000,00036,251,0000.58reported discrete quarter
2024-Q32024-07-28210,984,00034,388,0000.55reported discrete quarter
2024-Q42024-10-31222,628,00033,869,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-02-02212,138,00042,851,0000.68reported discrete quarter
2025-Q22025-05-04210,992,0008,861,0000.15reported discrete quarter
2025-Q32025-08-03210,394,00022,891,0000.39reported discrete quarter
2025-Q42025-10-31215,770,00061,801,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-02-01225,066,00042,939,0000.74reported discrete quarter
2026-Q22026-05-03209,940,00031,429,0000.54reported discrete quarter

Quarterly Charts

PLAB quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.PLAB quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.PLAB Quarterly RevenueLatest point: 2026-Q2 = $209.9MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Revenue$0.0B$125.0M$250.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-05-03; accession 0001140361-26-024915; filed 2026-06-11. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

PLAB quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.PLAB quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.PLAB Quarterly Net incomeLatest point: 2026-Q2 = $31.4MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Net income$0.0B$125.0M$250.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-05-03; accession 0001140361-26-024915; filed 2026-06-11. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

PLAB quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.PLAB quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.PLAB Quarterly Diluted EPSLatest point: 2026-Q2 = $0.54/shareSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Diluted EPS (USD/share)$0.00/share$0.50/share$1.00/share2022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-05-03; accession 0001140361-26-024915; filed 2026-06-11. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Macro Cross-References

Latest quarter (10-Q)

Latest 10-Q source: 0001140361-26-024915.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-06-11. Report date: 2026-05-03.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

Management’s discussion and analysis (“MD&A”) of the Company’s financial condition and results of operations should be read in conjunction with its condensed consolidated financial statements and related notes. Various sections of this
MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company’s Form 10-K for fiscal
year 2025), that may cause actual results to materially differ from these expectations. See “Cautionary Statement Regarding Forward-Looking Statements”.

We sell substantially all of our photomasks to designers and manufacturers of IC and FPD electronic devices. Photomask technology is also being applied to the fabrication of other high-technology products including
advanced packaging modules, micro-optical components for applications such as virtual reality/augmented reality and silicon photonics, micro-electronic mechanical systems (MEMS), and diverse nanotechnology applications. Our selling cycle is
tightly interwoven with the development and release of new semiconductor and display designs and applications, particularly as they relate to the semiconductor industry’s migration to more advanced design nodes and fabrication processes. The
demand for photomasks is primarily correlated with new product design activity and to a lesser extent scaling up of manufacturing of end products. Consequently, an increase in semiconductor or display sales does not always result in a
corresponding increase in photomask sales. To the extent integrated circuit and flat panel display applications rely less on new design activity, it could result in a reduction in demand for photomasks. In addition, new design methodologies
driving a reduction in complexity of photomasks could also reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. More broadly, advances in semiconductor, display, and photomask design and production methods
that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. While there is no indication today that such diminishing of long-range photomask demand is occurring or will occur, the
microelectronics industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These negative trends have been characterized by, among other things, diminished product demand, excess production capacity, and
accelerated erosion of selling prices with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for
IC photomasks and two to three weeks of backlog for FPD photomasks. However, the demand for some IC photomasks can extend longer than the traditional time period; thus, for some products, our backlog can expand to as long as two to three
months.

The global semiconductor and FPD industries are driven by end markets which have broad application in the global economy including but not limited to consumer-driven applications, data centers that support AI
implementation, electric vehicles and national security. While we cannot predict the timing of the industry’s transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we
believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these
environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

We are focused on improving our competitiveness by advancing our technology and reducing costs and, in connection therewith, have invested and plan to continue to invest in manufacturing equipment to serve both
the high-end and mainstream photomask markets. As we face challenges that require us to make significant improvements in our competitiveness, we continue to implement programs to streamline, drive efficiency and reduce costs in our
infrastructure.

State-of-the-art production for semiconductor masks is considered to be 4 or 5 nanometer and smaller including EUV lithography for ICs and Generation 8.6 AMOLED display-based process technologies for FPDs. However,
we define our high-end product category as 28nm and below for semiconductors and Generation 10.5 plus, Generation 6 and 8 AMOLED and LTPS for displays. This is consistent with current merchant mask industry definitions. Moreover, design nodes
above 28nm and FPD processes for standard LCD displays below Generation 10 are considered mainstream or standard products. At these geometries and various high-end nodes, we can produce full lines of photomasks, and there is no significant
technology employed by our competitors that is not available to us. We expect advanced-generation designs to continue to move to production throughout fiscal 2026, and we believe we are well positioned to service an increasing volume of this
business as a result of our investments in manufacturing processes and technology in the regions where our customers are located.

26

Table of Contents

The photomask industry has been and is expected to continue to be characterized by technological change and evolving industry standards. In order to remain competitive, we will be required to continually
anticipate, respond to, and utilize changing technologies. In particular, we believe that, as semiconductor geometries continue to become smaller and/or more complex, and display designs become larger or otherwise more advanced, we will be
required to manufacture even more complex products, including photomasks with advanced optical proximity correction, insertion of curvilinear patterning and EUV photomasks. Additionally, demand for photomasks has been, and could in the future
be, adversely affected by changes in high-performance electronics fabrication methods that affect the type or quantity of photomasks used, such as changes in semiconductor demand that favor programmable IC devices and other approaches that
replace application-specific ICs, or the use of certain chip-stacking methodologies that lessen the emphasis on conventional lithography technology. Furthermore, increased market acceptance of alternative methods of transferring circuit designs
onto semiconductor wafers could reduce or eliminate the need for photomasks in the production of semiconductors.

Our revenues have benefited, and our costs, including depreciation, have been affected by the increased demand for high-end-technology photomasks that require more advanced manufacturing capabilities, but generally
command higher ASPs. Our year-to-date capital expenditure payments were $93.4 million and $95.7 million in Q2 FY26 and Q2 FY25, respectively. Nonetheless, we intend to continue to make the required investments to support the technological and
production requirements of our customers that we believe will continue to enable our growth. This includes investments to replace end-of-life mask-making equipment with higher-performing systems that better serve our customers. In support of
this effort, we expect capital expenditure payments to be approximately $330 million in fiscal year 2026.

The manufacture of photomasks for use in fabricating ICs, FPDs, and other related products built using comparable photomask-based process technologies has been, and continues to be, capital intensive. Our employees
and our integrated global manufacturing network represent a significant portion of our fixed operating cost base. Should our revenue decrease as a result of a decrease in design releases from our customers, we may have excess or underutilized
production capacity, which could significantly impact our operating margins, or result in write-offs from asset impairments.

27

Table of Contents

Results of Operations

All the following tabular comparisons, unless otherwise indicated, are for the three-month and six-month periods ended May 3, 2026 (Q2 FY26), February 1, 2026 (Q1 FY26) and May 4, 2025 (Q2 FY25). The tables in this
section may not foot due to rounding.

The following tables present selected operating information expressed as a percentage of revenue.

Three Months EndedSix Months Ended
May 3,February 1,May 4,May 3,May 4,
20262026202520262025
Revenue100.0%100.0%100.0%100.0%100.0%
Cost of goods sold68.765.063.166.863.7
Gross profit31.335.036.933.236.3
Selling, general, and administrative9.99.58.69.78.8
Research and development1.31.11.91.22.0
Operating income20.124.426.422.325.5
Other income (expense), net5.68.7(12.2)7.2(0.2)
Income before income tax provision25.733.114.229.525.3
Income tax provision5.16.42.75.75.8
Net income20.626.711.523.819.5
Net income attributable to noncontrolling interests5.67.77.36.77.3
Net income attributable to Photronics, Inc. shareholders15.0%19.1%4.2%17.1%12.2%

28

Table of Contents

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically impacted during the first quarter of our fiscal year by the North
American, European, and Asian holiday periods, as some of our customers may adjust their buying activities during those periods.

The following tables present changes in revenue disaggregated by product type and geographic origin, in Q2 FY26 from revenue in prior reporting periods.

Quarterly Changes in Revenue by Product Type ($ in millions)

[[GREPCENT_TABLE]]
[["","","Q2 FY26 compared with Q1 FY26","","","Q2 FY26 compared with Q2 FY25","","","YTD FY26 compared with YTD FY25"],["","","Revenue in","","","Increase","","","Percent","","","Increase","","","Percent","","","Revenue in","","","Increase","","","Percent"],["","","Q2 FY26","","","(Decrease)","","","Change","","","(Decrease)","","","Change","","","YTD FY26","","","(Decrease)","","","Change"],["IC"],["High-end*","","$","56.7","","","$","(14.6",")","","","(20.5",")%","","$","(2.6",")","","","(4.5",")%","","$","127.9","","","$","8.5","","","","7.1","%"],["Mainstream","","","90.8","","","","(3.3",")","","","(3.4",")%","","","(5.8",")","","","(5.9",")%","","","184.9","","","","(5.5",")","","","(2.9",")%"],["Total IC","","$","147.5","","","$","(17.9",")","","","(10.8",")%","","$","(8.4",")","","","(5.4",")%","","$","312.8","","","$","3.0","","","","1.0","%"],["FPD"],["High-end*","","$","52.8","","","$","5.9","","","","12.5","%","","$","9.2","","","","21.1","%","","$","99.8","","","$","6.5","","","","7","%"],["Mainstream","","","9.6","","","","(3.2",")","","","(25.1",")%","","","(1.9",")","","","(16.5",")%","",

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A

Extracted from a substantive MD&A body after the formal Item 7 span was a TOC or reference stub. Confidence: high. Filing date: 2025-12-17. Report date: 2025-10-31.

Overview

We sell substantially all of our photomasks to designers and manufacturers of IC and FPD electronic devices.  Photomask technology is also being applied to the fabrication of other high-technology products including
advanced packaging modules, micro optical components for applications such as virtual reality/augmented reality and silicon photonics, micro-electronic mechanical systems (MEMS), and diverse nanotechnology applications. Our selling cycle is
tightly interwoven with the development and release of new semiconductor and display designs and applications, particularly as they relate to the semiconductor industry's migration to more advanced design nodes and fabrication processes. The
demand for photomasks is primarily correlated with new product design activity and to a lesser extent scaling up of manufacturing of end products. Consequently, an increase in semiconductor or display sales does not always result in a
corresponding increase in photomask sales. To the extent integrated circuit and flat panel display applications rely less on new design activity, it could result in a reduction in demand for photomasks. In addition, new design methodologies
driving a reduction in complexity of photomasks could also reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. More broadly, advances in semiconductor, display, and photomask design and production methods that
shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. While there is no indication today that such diminishing of long range photomask demand is occurring or will occur, the
microelectronics industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These negative trends have been characterized by, among other things, diminished product demand, excess production capacity, and
accelerated erosion of selling prices with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC
photomasks and two to three weeks of backlog for FPD photomasks. However, the demand for some IC photomasks can extend longer than the traditional time period; thus, for some products, our backlog can expand to as long as two to three months.

The global semiconductor and FPD industries are driven by end markets which have broad application in the global economy including but not limited to consumer-driven applications, data centers that support AI
implementation, electric vehicles and national security. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we
believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments
is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

We are focused on improving our competitiveness by advancing our technology and reducing costs and, in connection therewith, have invested and plan to continue to invest in manufacturing equipment to serve both the
high-end photomask and mainstream markets. As we face challenges that require us to make significant improvements in our competitiveness, we continue to implement programs to streamline, drive efficiency and reduce cost in our infrastructure.

State-of-the-art production for semiconductor masks is considered to be 7 nanometer and smaller including EUV lithography for ICs and Generation 8.6 AMOLED display-based process technologies for FPDs. However, we
define our high-end product category as 28nm and below for semiconductors and Generation 10.5 plus, Generation 6 and 8 AMOLED and LTPS for displays. This is consistent with current merchant mask industry definitions. Moreover, design nodes above
28nm and FPD processes for standard LCD displays below Generation 10 are considered mainstream or standard products. At these geometries and various high-end nodes, we can produce full lines of photomasks, and there is no significant technology
employed by our competitors that is not available to us. We expect advanced-generation designs to continue to move to production throughout fiscal 2026, and we believe we are well positioned to service an increasing volume of this business as a
result of our investments in manufacturing processes and technology in the regions where our customers are located.

24

Table of Contents

The photomask industry has been, and is expected to continue to be characterized by technological change and evolving industry standards. In order to remain competitive, we will be required to continually anticipate,
respond to, and utilize changing technologies. In particular, we believe that, as semiconductor geometries continue to become smaller, and display designs become larger or otherwise more advanced, we will be required to manufacture even more
complex products, including photomasks with optical proximity correction, phase-shift and EUV photomasks. Additionally, demand for photomasks has been, and could in the future be, adversely affected by changes in high-performance electronics
fabrication methods that affect the type or quantity of photomasks used, such as changes in semiconductor demand that favor programmable IC devices and other approaches that replace application-specific ICs, or the use of certain chip-stacking
methodologies that lessen the emphasis on conventional lithography technology. Furthermore, increased market acceptance of alternative methods of transferring circuit designs onto semiconductor wafers could reduce or eliminate the need for
photomasks in the production of semiconductors.

Our revenues have benefited, and our costs, including depreciation, have been affected by the increased demand for high-end-technology photomasks that require more advanced manufacturing capabilities, but generally
command higher ASPs. Our capital expenditure payments were $188.1 million, $130.9 million and $131.3 million in 2025, 2024 and 2023, respectively. Nonetheless, we intend to continue to make the required investments to support the technological and
production requirements of our customers that we believe will continue to enable our growth. This includes investments to replace end-of-life mask-making equipment with higher-performing systems that better serve our customers. In support of this
effort, we expect capital expenditure payments to be approximately $330 million in fiscal year 2026.

The manufacture of photomasks for use in fabricating ICs, FPDs, and other related products built using comparable photomask-based process technologies has been, and continues to be, capital intensive. Our employees and
our integrated global manufacturing network represent a significant portion of our fixed operating cost base. Should our revenue decrease as a result of a decrease in design releases from our customers, we may have excess or underutilized
production capacity, which could significantly impact our operating margins, or result in write-offs from asset impairments.

25

Table of Contents

Results of Operations

The following tables present selected operating information expressed as a percentage of revenue. The columns may not foot due to rounding.

Three Months Ended
October 31, 2025August 3, 2025October 31, 2024
Revenue100.0%100.0%100.0%
Cost of goods sold65.066.363.0
Gross profit35.033.737.0
Selling, general and administrative expenses9.38.89.4
Research and development expenses1.52.02.4
Operating income24.122.925.2
Non-operating (expense) income, net11.1(4.5)(0.5)
Income before income tax provision35.218.424.7
Income tax (benefit) provision(1.2)4.66.5
Net income36.413.818.2
Net income attributable to noncontrolling interests7.83.02.9
Net income attributable to Photronics, Inc. shareholders28.6%10.9%15.3%
Year Ended
October 31, 2025October 31, 2024October 31, 2023
Revenue100.0%100.0%100.0%
Cost of goods sold64.763.662.3
Gross profit35.336.437.7
Selling, general and administrative expenses8.99.07.8
Research and development expenses1.91.91.5
Operating income24.525.628.4
Non-operating income1.63.01.9
Income before income tax provision26.128.530.3
Income tax provision3.77.37.9
Net income22.421.222.4
Net income attributable to noncontrolling interests6.36.18.3
Net income attributable to Photronics, Inc. shareholders16.1%15.1%14.1%

Note: All the following tabular comparisons, unless otherwise indicated, are for the three months ended October 31, 2025 (Q4 FY25), August 3, 2025 (Q3 FY25) and October 31,
2024 (Q4 FY24), and for the fiscal years ended October 31, 2025 (YTD FY25), October 31, 2024 (YTD FY24), and October 31, 2023 (YTD FY23). Please refer to Part II, Item 7 of our 2024 Form 10-K for comparative discussion of our fiscal years ended
October 31, 2024, and October 31, 2023. The tables in this section (Part II, Item 7) may not foot due to rounding.

26

Table of Contents

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first quarter of our fiscal year by the North
American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

The following tables present changes in revenue disaggregated by product type and geographic origin, in Q4 FY25 and YTD FY25 from revenue in prior reporting periods.

Quarterly Changes in Revenue by Product Type ($ in millions)

Q4 FY25 compared with Q3 FY25Q4 FY25 compared with Q4 FY24
Revenue inIncreasePercentIncreasePercent
Q4 FY25(Decrease)Change(Decrease)Change
IC
High-end *$65.8$12.222.7%$5.89.6%
Mainstream91.6(2.5)(2.7)%(12.1)(11.6)%
Total IC$157.4$9.76.5%$(6.3)(3.8)%
FPD
High-end *$48.7$(4.8)(8.9)%$0.40.8%
Mainstream9.60.55.5%(0.9)(8.8)%
Total FPD$58.3$(4.3)(6.8)%$(0.5)(0.9)%
Total Revenue$215.8$5.42.6%$(6.8)(3.1)%

* High-end photomasks typically have higher ASPs than mainstream products.

Quarterly Changes in Revenue by Geographic Origin ($ in millions) **

Q4 FY25 compared with Q3 FY25Q4 FY25 compared with Q4 FY24
Revenue inIncreasePercentIncreasePercent
Q4 FY25(Decrease)Change(Decrease)Change
Taiwan$67.3$(1.1)(1.6)%$(2.4)(3.4)%
China58.17.514.8%(2.7)(4.5)%
South Korea37.0(6.7)(15.4)%(3.0)(7.5)%
United States43.55.715.3%1.84.2%
Europe9.0(0.1)(1.3)%(0.9)(9.4)%
Other0.90.111.1%0.487.2%
Total revenue$215.8$5.42.6%$(6.8)(3.1)%

** This table disaggregates revenue by the location in which it was earned.

27

Table of Contents

Revenue in Q4 FY25 of $215.8 million represented an increase of 2.6% compared with Q3 FY25, and a decrease of 3.1% from Q4 FY24.

Overall IC revenue increased $9.7 million or 6.5% in Q4 FY25 from Q3 FY25 due to strong order patterns globally including the U.S. IC revenue decreased $6.3 million or 3.8% from Q4 FY24, as a result of a decline
in maintream products partially offset by an increase in high-end demand. IC mainstream revenue decreased $2.5 million or 2.7% from Q3 FY25, and $12.1 million or 11.6% from Q4 FY24 primarily due to market conditions and geopolitical impacts.

FPD revenue decreased $4.3 million or 6.8% in Q4 FY25 from Q3 FY25, and $0.5 million or 0.9% from Q4 FY24 mainly due to the decrease in high-end products, which decreased $4.8 million or 8.9% in Q4 FY25 from Q3 FY25 due to timing of
order patterns.

Year-over-Year Changes in Revenue by Product Type ($ in millions)

YTD FY25 compared with YTD FY24
Revenue inIncreasePercent
YTD FY25(Decrease)Change
IC
High-end *$238.9$10.44.6%
Mainstream376.2(33.4)(8.2)%
Total IC$615.1$(23.0)(3.6)%
FPD
High-end *$195.5$0.20.1%
Mainstream38.75.215.7%
Total FPD$234.2$5.42.4%
Total Revenue$849.3$(17.6)(2.0)%

* High-end photomasks typically have higher ASPs than mainstream photomasks.

Year-over-Year Changes in Revenue by Geographic Origin ($ in millions)**

YTD FY25 compared with YTD FY24
Revenue inIncreasePercent
YTD FY25(Decrease)Change
Taiwan$283.8$(4.4)(1.5)%
China221.0(11.9)(5.1)%
South Korea158.50.50.3%
United States148.92.31.5%
Europe34.2(5.2)(13.2)%
Other2.91.161.3%
$849.3$(17.6)(2.0)%

** This table disaggregates revenue by the location in which it was earned.

28

Table of Contents

Overall revenue decreased $17.6 million or 2.0% in YTD FY25 from YTD FY24, driven by a $23.0 million or 3.6% decrease in IC revenue due to lower demand for mainstream
products earlier in the year, partially offset by strong demand for high-end products. FPD revenue increased by $5.4 million or 2.4%, driven by a $5.2 million or 15.7% increase in mainstream product revenue due to an increase in G8 products.

Gross Margin

PercentPercent
Q4 FY25Q3 FY25ChangeQ4 FY24Change
Gross profit$75.5$70.96.5%$82.3(8.3)%
Gross margin35.0%33.7%37.0%

Gross margin increased to 35% in Q4 FY25 from 33.7% in Q3 FY25, primarily due to favorable product mix and lower manufacturing cost, partially offset by higher overhead costs.

Gross margin decreased to 35% in Q4 FY25 from 37% in Q4 FY24, primarily due to unfavorable product mix and higher labor costs, partially offset by lower equipment costs as a percentage of revenue.

Percent
YTD FY25YTD FY24Change
Gross profit$299.8$315.9(5.1)%
Gross margin35.3%36.4%

Gross margin decreased to 35.3% in YTD FY25 from 36.4% in YTD FY24, primarily due to increased material costs resulting from unfavorable product mix.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $20.0 million in Q4 FY25, compared with $18.4 million in Q3 FY25, and $21.0 million in Q4 FY24. The $1.6 million increase from Q3 FY25 was primarily the result of
additional compensation and related expenses of $1.2 million. The $1.0 million decrease from Q4 FY24 was primarily the result of decreased professional fees of $0.5 million.

Selling, general and administrative expenses were $75.6 million in YTD FY25, compared with $77.8 million in YTD FY24.  The decrease of $2.2 million is primarily due to a decrease in compensation and related
expenses of $1.1 million and professional fees of $1.0 million.

Research and Development Expenses

Research and development expenses, which primarily consist of development and qualification efforts related to process technologies for high-end IC and FPD applications, decreased $1.1 million to $3.2 million in Q4 FY25, from Q3 FY25; the
decrease was primarily caused by decreased qualification activities in the U.S. Research and development expenses in Q4 FY25 decreased by $2.1 million from Q4 FY24 as a result of decreased development activities in the U.S. and Asia. On a
full year basis, research and development expenses decreased $0.8 million, to $15.8 million, primarily due to decreased development activities in Asia, partially offset by increased research and development activity in the U.S.

29

Table of Contents

Other Income (Expense), net

Q4 FY25Q3 FY25Q4 FY24
Foreign currency transactions impact, net$18.6$(14.3)$(7.7)
Interest expense, net--(0.1)
Interest income and other income, net5.34.86.8
Other income (expense), net$23.9$(9.4)$(1.0)

Other income increased $33.3 million in Q4 FY25 from Q3 FY25 and $24.9 million from Q4 FY24, primarily due to foreign currency impacts. The foreign currency impacts were primarily driven by favorable movements of the New Taiwan dollar and
the South Korean won, against the U.S. dollar for both periods.

YTD FY25YTD FY24
Foreign currency transactions impact, net$(8.3)$2.2
Interest expense, net(0.1)(0.3)
Interest income and other income, net22.024.0
Other income (expense), net$13.6$25.9

Other income decreased $12.3 million in YTD FY25, compared with YTD FY24, due to unfavorable movements of the New Taiwan dollar and the South Korean won, against the U.S. dollar for the period.

30

Table of Contents

Income Tax Provision

Q4 FY25Q3 FY25Q4 FY24
Income tax provision$(2.7)$9.6$14.6
Effective income tax rate(3.5)%24.8%26.6%

The effective income tax rates are sensitive to the jurisdictional mix of our earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances.

The effective income tax rate decreased in Q4 FY25 compared with Q3 FY25 primarily due to the release of a $16.7 million valuation allowance related to deferred tax assets that are now expected to be realized in
future periods, as well as $2.8 million of reversals of uncertain tax positions mainly resulting from audit settlements and statute expirations. These favorable items were partially offset by $7.1 million of foreign tax rate differentials
driven by higher income levels during the quarter. In addition, the effective tax rate was impacted by an unfavorable jurisdictional mix of earnings.

The effective income tax rate decrease in Q4 FY25, compared with Q4 FY24, is primarily due to the impact of the change in valuation allowance described above, changes in the jurisdictional mix of earnings, and a
decrease in foreign tax compared with the prior year.

YTD FY25YTD FY24
Income tax provision$31.6$63.6
Effective income tax rate14.2%25.7%

The decrease in the effective income tax rate on a full-year basis in FY25, compared with FY24, is primarily due to the release of valuation allowance as described above. We also regularly assess the potential
outcomes of ongoing and future tax examinations and, accordingly, have recorded accruals for such contingencies. Included in the balance of unrecognized tax benefits as of October 31, 2025 and October 31, 2024, are $11.4 million and $14.7
million respectively, recorded in Other liabilities in the consolidated balance sheets that, if recognized, would impact the effective tax rates.

31

Table of Contents

On December 15, 2022, the European Union (EU) Member States formally adopted the EU’s Pillar Two Directive, which generally provides for a minimum effective tax rate of 15%, as established by the Organization for
Economic Co-operation and Development (OECD) Pillar Two Framework. The EU effective dates are January 1, 2024, and January 1, 2025, for different aspects of the directive. A significant number of other countries are expected to continue to
implement similar legislation with varying effective dates.

The Company is currently subject to Pillar Two, but we estimate that the financial impact is immaterial. We will continue to monitor further developments to determine any potential impact in the countries in which
we operate.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. The OBBBA includes significant changes to federal tax law and other regulatory provisions that may impact the Company. The
legislation enacted will be effective for Photronics commencing in our fiscal year 2026. We will continue to monitor and evaluate the impact of the legislative changes as more guidance becomes available.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $16.8 million in Q4 FY25, compared with $6.2 million in Q3 FY25; the increase of $10.6 million was the result of an increase in the net incomes of our joint
venture operations. Net income attributable to noncontrolling interests increased $10.5 million in Q4 FY25, compared with $6.4 million in Q4 FY24; which was the result of an increase in the net incomes of our joint venture operations.

Net income attributable to noncontrolling interests increased by $0.7 million in YTD FY25 to $53.8 million from $53.2 million in YTD FY24, as a result of increased net income at both our Taiwan-based and
China-based joint venture IC facilities.

Liquidity and Capital Resources

Cash and cash equivalents were $492.3 million and $598.5 million as of October 31, 2025, and October 31, 2024, respectively. As of October 31, 2025, total cash and cash equivalents included $446.1 million held by
foreign subsidiaries, including an aggregate of $353.8 million held by our joint ventures in Taiwan and China. In addition, we currently have $95.9 million in short-term investments and CNY 200 million or USD 25 million of borrowing capacity in
China to support local operations. See Note 8 – Debt to the consolidated financial statements for additional information on our outstanding debt and currently
available financing. Our primary sources of liquidity are our cash on hand and cash we generate from operations.

We continually evaluate alternatives for efficiently funding our capital expenditures and ongoing operations. These reviews may result in our engagement in a variety of investing and financing transactions, in the
transfer of cash among subsidiaries, and/or the repatriation of cash to the U.S. The transfer of funds among subsidiaries could be subject to foreign withholding taxes; in certain jurisdictions, repatriation of these funds to the U.S. may
subject them to U.S. state income taxes and/or local country withholding taxes. We believe that our liquidity, including available financing, is sufficient to meet our requirements through the next twelve months and thereafter for the
foreseeable future. Through the utilization of our existing liquidity, cash we generate from operations and short-term investments, we plan to continue to invest in our business, with our investments targeted to align with our customers’
technology road maps. In addition, we stand ready to invest in mergers, acquisitions, or strategic partnerships, should a suitable opportunity arise.

We estimate capital expenditures for our fiscal year 2026 will be approximately $330 million; these investments will be targeted towards high-end and mainstream “point” tools that will increase our operating
capacity and efficiency and enable us to support our customers’ near-term demands. As of October 31, 2025, we had outstanding capital commitments of approximately $126.4 million and accrued liabilities related to capital equipment purchases of
approximately $13.0 million. Although payment timing could vary, primarily as a result of the timing of tool delivery, installation and testing, we currently estimate that we will fund $120.0 million of our total $139.4 million committed and
recognized obligations for capital expenditures over the next twelve months. Please refer to Notes 11 - Leases and 16 – Commitments and Contingencies to our consolidated financial statements for additional information on our lease liabilities
and unrecognized commitments, respectively.

32

Table of Contents

On August 28, 2024, the Board of Directors authorized an increase to the Company’s existing share repurchase program from the remaining $31.7 million to $100 million. In June 2025, the Board of Directors authorized
an additional $25 million share repurchase. During the fiscal year ended as of October 31, 2025, the Company repurchased 5.0 million shares for $97.4 million. As a result, as of October 31, 2025, $27.6 million remained available under this
authorization. Depending on market conditions, we may utilize some or the entire remaining approved amount to reacquire additional shares.

As discussed in Note 6 – PDMCX Joint Venture of our consolidated financial statements, DNP, the noncontrolling interest in our
China-based joint venture has, under certain circumstances, the right to put its interest in the joint venture to Photronics, or to purchase our interest in the joint venture. Under all such circumstances, the sale of DNP’s interest would be at
its ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. As of the date of issuance of this report, DNP had not indicated its intention
to exercise this right. As of October 31, 2025, Photronics and DNP each had net investments in this joint venture of approximately $160.4 million.

Cash Flows

Year Ended
October 31, 2025October 31, 2024October 31, 2023
Net cash provided by operating activities$247.8$261.4$302.2
Net cash used in investing activities$(238.9)$(156.5)$(101.5)
Net cash used in financing activities$(115.3)$(7.7)$(18.5)

Operating Activities: Net cash
provided by operating activities reflects net income adjusted for certain non-cash items, including depreciation and amortization, share-based compensation, and the effects of changes in operating assets and liabilities. Net cash provided by
operating activities decreased by $13.6 million in FY25, compared with FY24, primarily due to unfavorable changes in working capital.

Investing Activities: Net cash used in investing activities increased by $82.4 million in FY25, compared to FY24,
primarily driven by an increase of purchases of short-term investments of $29.0 million and purchases of property, plant, and equipment of $57.2 million.

Financing Activities: Net cash used in financing activities increased by $107.6 million in FY25, compared to
FY24.  This was driven by an increase in repurchases of common stock of $97.4 million and repayments of debt of $11.4 million.

Our cash, cash equivalents, and restricted cash balances were positively impacted by changes in foreign currency exchange rates in FY25 of $0.2 million.

Non-GAAP Financial Measures

Non-GAAP Net Income attributable to Photronics, Inc. shareholders and non-GAAP diluted earnings per share attributable to Photronics, Inc. shareholders are “non-GAAP financial measures” as such term is defined by Regulation G of the
Securities and Exchange Commission and may differ from similarly named non-GAAP financial measures used by other companies. The financial tables below reconcile Photronics, Inc. financial results under U.S. GAAP to our non-GAAP financial
information. We believe these non-GAAP financial measures that exclude certain items are useful for analysts and investors to evaluate the Company’s on-going performance because they enable a more meaningful comparison of historical results of
the Company’s core business. These non-GAAP metrics are not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss), Net income (loss) per share, or any other measure of
consolidated results under U.S. GAAP. The items excluded from these non-GAAP metrics but included in the calculation of their closest U.S. GAAP equivalent, are significant components of the condensed consolidated statement of income and must be
considered in performing a comprehensive assessment of overall financial performance.

33

Table of Contents

The following table reconciles U.S. GAAP net income and diluted earnings per share attributable to Photronics, Inc. shareholders to non-GAAP net income and diluted earnings per share attributable to Photronics,
Inc. shareholders for the indicated periods. The columns may not foot due to rounding.

Three Months endedYear ended
Oct 31,Aug 3,Oct 31,Oct 31,Oct 31,Oct 31,
202520252024202520242023
Reconciliation of U.S. GAAP to non-GAAP net income:
U.S. GAAP net income attributable to Photronics, Inc. shareholders$61,801$22,891$33,869$136,405$130,688$125,485
FX (gain) loss(18,615)14,2587,7588,310(2,168)(2,466)
Estimated tax effects of FX (gain) loss4,781(3,663)(1,936)(2,066)477317
Estimated noncontrolling interest effects of above3,341(4,130)(2,637)(5,342)(1,407)2,676
Reversal of deferred tax valuation allowance(16,751)--(16,751)--
Non-GAAP net income attributable to Photronics, Inc. shareholders$34,557$29,356$37,054$120,556$127,590$126,012
Weighted-average number of common shares outstanding - Diluted57,97758,06862,45659,92062,39161,755
Reconciliation of U.S. GAAP to non-GAAP EPS:
U.S. GAAP diluted earnings per share attributable to Photronics, Inc. shareholders$1.07$0.39$0.54$2.28$2.09$2.03
Effects of the non-GAAP adjustments above(0.47)0.120.05(0.27)(0.04)0.01
Non-GAAP diluted earnings per share attributable to Photronics, Inc. shareholders$0.60$0.51$0.59$2.01$2.05$2.04

Business Outlook

Our current business outlook and guidance was provided in our Full Year and Fourth Quarter Fiscal 2025 Results earnings call, and related slide deck, but is not incorporated herein. These can be accessed in the
investor section of our website - www.photronics.com. Information included on our website is not incorporated in this Form 10-K.

Our future results of operations and the other forward-looking statements contained in this filing and in our “Full Year and Fourth Quarter Fiscal 2025 Results” earnings call and presentation involve a number of
risks and uncertainties, some of which are discussed in Part I, Item 1A of this report. These factors and a number of other unforeseeable factors could cause actual results to differ materially from our expectations.

34

Table of Contents

Critical Accounting Estimates

Our consolidated financial statements are based on the selection and application of accounting policies, which require management to make significant estimates and assumptions. We believe the following to be the
more critical areas that require judgment when applying our accounting policies:

Column 1Column 2Column 3
Revenue Recognition: The application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates, including the determination of whether we should recognize revenue as we perform or upon the completion of our performance, as these determinations impact the timing and amount of our reported revenue and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to recognize revenue, as well as the measurement of our progress towards satisfying our performance obligations, which determine the amount of revenue we are entitled to recognize.
Column 1Column 2Column 3
Property, Plant and Equipment: Significant judgment and assumptions are employed when we establish the estimated useful lives of asset classes, and determine when depreciation should commence for individual assets, as these determinations can significantly impact our gross margin and research and development expenses. Significant judgment would also be employed when events or changes in circumstances indicate that the carrying amount of a group of assets may not be recoverable, as the recoverability assessment requires us to forecast future cash flows related to these assets; this evaluation can significantly impact our gross margin and operating expense.
Column 1Column 2Column 3
Leases: Significant judgment is applied in the determination of whether an arrangement is, or contains, a lease and, in certain instances, whether the lease should be classified as an operating lease or a finance lease, which can impact the timing and classification of lease costs.
Column 1Column 2Column 3
Contingencies: We are subject to the possibility of losses from various contingencies. Significant judgment is necessary to estimate the probability and amount of a loss, if any, from such contingencies. An accrual is made when it is probable that a liability has been incurred or an asset has been impaired and the amount of loss can be reasonably estimated. Changes in estimates related to, and resolutions of, contingencies may have a material impact on our financial performance.
Column 1Column 2Column 3
Income Taxes: Our annual tax rate is determined based on our income and the jurisdictions where it is earned, statutory tax rates, and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Also inherent in determining our annual tax rate are judgments and assumptions regarding the recoverability of certain deferred tax assets, and our ability to uphold certain tax positions. We are subject to complex tax laws, in the U.S. and numerous foreign jurisdictions, and the manner in which they apply can be open to interpretation. Realization of deferred tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction in future periods, which involves business plans, planning opportunities, and expectations about future outcomes. Our assessment relies on estimates and assumptions and may involve a series of complex judgments about future events.

There are a number of estimates and assumptions inherent in calculating the various components of our tax provision. Future events such as changes in tax legislation, geographic mix of
earnings, findings in tax audits, and earnings repatriation plans could have an impact on those estimates and our effective tax rate.

Effect of Recent Accounting Pronouncements

See Note 1 to our consolidated financial statements in this report for recent accounting pronouncements that may affect our financial reporting.

35

Table of Contents

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. The latest 10-K appears above; prior years are below.

FY 2024 10-K MD&A

SEC filing source: 0001140361-24-049881.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2024-12-19. Report date: 2024-10-31.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following should be read in conjunction with “Cautionary Statement Regarding Forward Looking Statements” and our combined consolidated financial statements and notes thereto included in Item 8
of this Annual Report on Form 10-K.

For a comparison of results of operations for the fiscal years ended October 31, 2023 and 2022, see Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of
Operations of Photronics Inc.’s Annual Report on Form 10-K for the fiscal year ended October 31, 2023, filed with the SEC on December 26, 2023.

Overview

We sell substantially all of our photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance
electronic products such as virtual reality/augmented reality advanced IC packages, photonics, micro-electronic mechanical systems, and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release
of new semiconductor and display designs and applications, particularly as they relate to the semiconductor industry’s migration to more advanced product innovation, design methodologies, and fabrication processes. The demand for photomasks
primarily depends on design activity rather than sales volumes from products manufactured using semiconductor manufacturing technologies. Consequently, an increase in semiconductor or display sales does not necessarily result in a corresponding
increase in photomask sales. However, the reduced use of application-specific ICs, reductions in design complexities, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of
new semiconductor or display designs could reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. Advances in semiconductor, display, and photomask design and production methods that shift the burden of achieving
device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronics industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These negative trends have been
characterized by, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC
photomasks and two to three weeks of backlog for FPD photomasks. However, the demand for some IC photomasks can extend longer than the traditional time period; thus, for some products, our backlog can expand to as long as two to three months.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices,
mobile communications, and computing solutions. While we cannot predict the timing of the industry’s transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we believe that
such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent
upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

We are focused on improving our competitiveness by advancing our technology and reducing costs and, in connection therewith, have invested and plan to continue to invest in manufacturing equipment to serve both the
high-end photomask and trailing-edge markets. As we face challenges that require us to make significant improvements in our competitiveness, we continue to evaluate further cost reduction initiatives.

State-of-the-art production for semiconductor masks is considered to be 28 nanometer and smaller for ICs and Generation 10.5+ and AMOLED and LTPS display-based process technologies for FPDs. However, 32 nanometer and
above geometries for semiconductors and Generation 8 and below (excluding AMOLED and LTPS) process technologies for displays constitute the majority of designs currently being fabricated in volume. At these geometries and various high-end nodes,
we can produce full lines of photomasks, and there is no significant technology employed by our competitors that is not available to us. We expect advanced-generation designs to continue to move to production throughout fiscal 2025, and we
believe we are well positioned to service an increasing volume of this business as a result of our investments in manufacturing processes and technology in the regions where our customers are located.

25

Table of Contents

The photomask industry has been, and is expected to continue to be characterized by technological change and evolving industry standards. In order to remain competitive, we will be required to continually anticipate,
respond to, and utilize changing technologies. In particular, we believe that, as semiconductor geometries continue to become smaller, and display designs become larger or otherwise more advanced, we will be required to manufacture even more
complex optically-enhanced reticles, including optical proximity correction, phase-shift and EUV photomasks. Additionally, demand for photomasks has been, and could in the future be, adversely affected by changes in high-performance electronics
fabrication methods that affect the type or quantity of photomasks used, such as changes in semiconductor demand that favor field-programmable gate arrays and other semiconductor designs that replace application-specific ICs, or the use of
certain chip-stacking methodologies that lessen the emphasis on conventional lithography technology. Furthermore, increased market acceptance of alternative methods of transferring circuit designs onto semiconductor wafers could reduce or
eliminate the need for photomasks in the production of semiconductors. As of the end of 2024, one alternative method, direct-write lithography, has not been proven to be a commercially viable alternative to photomasks, as it is considered to be
too slow for high-volume semiconductor wafer production, and we have not experienced a significant loss of revenue as a result of this or other alternative semiconductor design methodologies. However, should direct-write lithography or any other
alternative method of transferring IC designs to semiconductor wafers without the use of photomasks achieve market acceptance, and we do not anticipate, respond to, or utilize these or other changing technologies due to resource, technological,
or other constraints, our business and results of operations could be materially adversely affected.

Our revenues have benefitted, and our costs, including depreciation, have been affected by the increased demand for high-end-technology photomasks that require more advanced manufacturing capabilities, but generally
command higher ASPs. Our capital expenditure payments were $130.9 million, $131.3 million and $112.3 million in 2024, 2023 and 2022, respectively. Nonetheless, we intend to continue to make the required investments to support the technological
requirements of our customers that we believe will continue to enable our growth. In support of this effort, we expect capital expenditure payments to be approximately $200 million in fiscal year 2025.

The manufacture of photomasks for use in fabricating ICs, FPDs, and other related products built using comparable photomask-based process technologies has been, and continues to be, capital intensive. Our employees
and our integrated global manufacturing network represent a significant portion of our fixed operating cost base. Should our revenue decrease as a result of a decrease in design releases from our customers, we may have excess or underutilized
production capacity, which could significantly impact our operating margins, or result in write-offs from asset impairments.

26

Table of Contents

Results of Operations

The following tables present selected operating information expressed as a percentage of revenue. The columns may not foot due to rounding.

Three Months Ended
October 31, 2024July 28, 2024October 31, 2023
Revenue100.0%100.0%100.0%
Cost of goods sold63.064.462.7
Gross profit37.035.637.3
Selling, general and administrative expenses9.49.27.4
Research and development expenses2.41.71.5
Operating income25.224.728.5
Non-operating (expense) income, net(0.5)4.88.2
Income before income tax provision24.729.536.7
Income tax provision6.56.78.9
Net income18.222.827.8
Net income attributable to noncontrolling interests2.96.58.2
Net income attributable to Photronics, Inc. shareholders15.3%16.3%19.6%
Year Ended
October 31, 2024October 31, 2023October 31, 2022
Revenue100.0%100.0%100.0%
Cost of goods sold63.662.364.3
Gross profit36.437.735.7
Selling, general and administrative expenses9.07.87.8
Research and development expenses1.91.52.2
Operating income25.628.425.7
Non-operating income3.01.93.3
Income before income tax provision28.530.329.0
Income tax provision7.37.97.3
Net income21.222.421.7
Net income attributable to noncontrolling interests6.18.37.3
Net income attributable to Photronics, Inc. shareholders15.1%14.1%14.4%

27

Table of Contents

Note: All the following tabular comparisons, unless otherwise indicated, are for the three months ended October 31, 2024 (Q4 FY24), July 28, 2024 (Q3 FY24) and October 31,
2023 (Q4 FY23), and for the fiscal years ended October 31, 2024 (YTD FY24), October 31, 2023 (YTD FY23), and October 31, 2022 (YTD FY22). Please refer to Part II, Item 7 of our 2023 Form 10-K for comparative discussion of our fiscal years ended
October 31, 2023, and October 31, 2022. The tables in this item may not foot due to rounding.

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first quarter of our fiscal year by the North
American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

The following tables present changes in revenue disaggregated by product type and geographic origin, in Q4 FY24 and YTD FY24 from revenue in prior reporting periods.

Quarterly Changes in Revenue by Product Type ($ in millions)

Q4 FY24 compared with Q3 FY24Q4 FY24 compared with Q4 FY23
Revenue in Q4 FY24Increase (Decrease)Percent ChangeIncrease (Decrease)Percent Change
IC
High-end *$60.1$10.621.3%$2.44.1%
Mainstream103.6(2.8)(2.5)%(3.2)(2.9)%
Total IC$163.7$7.85.0%$(0.8)(0.5)%
FPD
High-end *$48.4$-0.0%$(4.9)(9.2)%
Mainstream10.53.856.6%0.88.3%
Total FPD$58.9$3.86.9%$(4.1)(6.5)%
Total Revenue$222.6$11.65.5%$(4.9)(2.1)%

* High-end photomasks typically have higher ASPs than mainstream products.

Quarterly Changes in Revenue by Geographic Origin ($ in millions) **

Q4 FY24 compared with Q3 FY24Q4 FY24 compared with Q4 FY23
Revenue in Q4 FY24Increase (Decrease)Percent ChangeIncrease (Decrease)Percent Change
Taiwan$69.7$1.52.3%$(9.6)(12.1)%
China60.85.510.0%1.62.7%
Korea40.01.64.1%(2.2)(5.2)%
United States41.72.97.6%5.013.5%
Europe9.90.11.0%0.55.7%
Other0.5-(1.2)%(0.2)(27.9)%
Total revenue$222.6$11.65.5%$(4.9)(2.1)%

** This table disaggregates revenue by the location in which it was earned.

28

Table of Contents

Revenue in Q4 FY24 of $222.6 million represented an increase of 5.5% compared with Q3 FY24, and a decrease of 2.1% from Q4 FY23.

Overall IC revenue increased $7.8 million or 5.0% in Q4 FY24 from Q3 FY24 due to stronger high-end foundry and logic demand in Asia.  Overall IC revenue decreased $0.8 million or 0.5% in Q4 FY24 from Q4 FY23.  IC
mainstream decreased in Q4 FY24 by $2.8 million or 2.5% from Q3 FY24, and $3.2 million or 2.9% from Q4 FY23 primarily the result of reduced mainstream demand in Asia.

FPD revenue increased $3.8 million or 6.9% in Q4 FY24 from Q3 FY24 due to stronger demand for mainstream products.  FPD revenue decreased $4.1 million or 6.5% in Q4 FY24 from Q4 FY23 due to slower demand in
high-end products. Revenue from mainstream products increased $3.8 million or 56.6% in Q4 FY24 from Q3 FY24 as more production capacity was dedicated to meet strong demand.

Year-over-Year Changes in Revenue by Product Type ($ in millions)

YTD FY24 compared with YTD FY23
Revenue in YTD FY24Increase (Decrease)Percent Change
IC
High-end *$228.5$33.517.2%
Mainstream409.6(46.7)(10.2)%
Total IC$638.1$(13.2)(2.0)%
FPD
High-end *$195.4$(5.5)(2.7)%
Mainstream33.4(6.5)(16.3)%
Total FPD$228.8$(12.0)(5.0)%
Total Revenue$866.9$(25.2)(2.8)%

* High-end photomasks typically have higher ASPs than mainstream photomasks.

Year-over-Year Changes in Revenue by Geographic Origin ($ in millions)**

YTD FY24 compared with YTD FY23
Revenue in YTD FY24Increase (Decrease)Percent Change
Taiwan$288.3$(28.6)(9.0)%
China232.9(12.4)(5.1)%
Korea158.0(4.2)(2.6)%
United States146.717.713.8%
Europe39.22.67.1%
Other1.8(0.3)(14.3)%
$866.9$(25.2)(2.8)%

** This table disaggregates revenue by the location in which it was earned.

29

Table of Contents

Overall revenue decreased $25.2 million or 2.8% in YTD FY24 from YTD FY23.  IC revenue decreased $13.2 million or 2.0% in YTD FY24 from YTD FY23 due to less demand for mainstream products earlier in the year which
was partially offset by strong demand for high-end products. FPD revenue decreased by $12.0 million or 5.0%, driven by a $6.5 million or 16.3% decrease in revenue from mainstream products due to a decrease in G8 products.

Gross Margin

Q4 FY24Q3 FY24Percent ChangeQ4 FY23Percent Change
Gross profit$82.3$75.19.6%$84.9(3.1)%
Gross margin37.0%35.6%37.3%

Gross margin increased by 140 basis points in Q4 FY24 as compared to Q3 FY24, primarily as a result of the increase in revenue.  The gross margin favorable impact
resulting from the increase in revenue in Q4 FY24 compared to Q3 FY24 was partially offset by increased material costs of 5.2%, or 6 basis points as a percentage of revenue. Labor costs increased 1.3%, or 45 basis points as a percentage of
revenue. Equipment and other overhead costs increased 2.7% from Q3 FY24 or 77 basis points as a percentage of revenue, mainly due to higher equipment cost in US high-end location.

Gross margin decreased by 30 basis points in Q4 FY24, from Q4 FY23, primarily as a result of the decrease in revenue of 2.1% and increased equipment and other
overhead costs of 4.6%, or 185 basis points as a percentage of revenue.  This was partially offset by a decrease in material cost of 5.2%, or 77 basis points as a percentage of revenue, and labor costs of 8.5%, or 74 basis points as a
percentage of revenue.

YTD FY24YTD FY23Percent Change
Gross profit$315.9$336.2(6.0)%
Gross margin36.4%37.7%

Gross margin decreased by 130 basis points in YTD FY24, from YTD FY23, primarily as a result of the decrease in revenue of 2.8% and increased equipment and other overhead costs of 2.5%, or 148 basis points as a
percentage of revenue.  This was partially offset by a decrease in material cost of 3.8%, or 24 basis points as a percentage of revenue, and labor costs of 2.8%, but remained flat as a percentage of revenue.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $21.0 million in Q4 FY24, compared with $19.4 million in Q3 FY24, and $16.7 million in Q4 FY23. The $1.6 million increase from Q3 FY24 was primarily the result of
compensation and related expenses of $1.1 million. The $4.3 million increase from Q4 FY23 was primarily the result of increased compensation and related compensation expenses of $2.1 million and increased professional fees of $1.4 million.

Selling, general and administrative expenses were $77.8 million in YTD FY24, compared with $69.5 million in YTD FY23.  The increase of $8.3 million is primarily due to an increase in compensation and related
expenses of $3.8 million and professional fees of $2.5 million.

Research and Development Expenses

Research and development expenses, which primarily consist of development and qualification efforts related to process technologies for high-end IC and FPD applications, increased $1.7 million
to $5.3 million in Q4 FY24, from Q3 FY24; the increase was primarily caused by increased qualification activities. Research and development expenses in Q4 FY24 increased by $1.9 million from Q4 FY23 as a result of increased development
activities in the U.S. and Asia. On a year-to-date basis, research and development expenses increased $2.9 million, to $16.6 million, primarily due to increased development activities in the U.S.

30

Table of Contents

Non-Operating Income (Expense)

Q4 FY24Q3 FY24Q4 FY23
Foreign currency transactions impact, net$(7.7)$4.1$13.2
Interest expense, net(0.1)(0.1)(0.1)
Interest income and other income, net6.86.15.6
Non-operating (expense) income, net$(1.0)$10.1$18.7

Non-operating (expense) income decreased in Q4 FY24 from Q3 FY24 by $11.1 million and from Q4
FY23 by $19.7 million, primarily due to foreign currency impacts. The foreign currency impacts were primarily driven by unfavorable movements of the New Taiwan dollar and the South Korean won, against the U.S. dollar for both
periods.

YTD FY24YTD FY23
Foreign currency transactions impact, net$2.2$2.5
Interest expense, net(0.3)(0.4)
Interest income and other income, net24.014.8
Non-operating income, net$25.9$16.9

Non-operating income (expense) increased $9.0 million in YTD FY24, compared with YTD FY23, due to increased interest income and other income of $9.2 million, resulting from higher average
cash, cash equivalents and short-term investments balances in FY24 as compared with FY23.

Income Tax Provision

On December 15, 2022, the European Union (EU) Member States formally adopted the EU’s Pillar Two Directive, which generally provides for a
minimum effective tax rate of 15%, as established by the Organization for Economic Co-operation and Development (OECD) Pillar Two Framework. The EU effective dates are January 1, 2024, and January 1, 2025, for different aspects of the
directive. A significant number of other countries are expected to also implement similar legislation with varying effective dates.  The Company is currently not subject to Pillar Two but is continuously evaluating the potential impact of the Pillar Two Framework to ensure we are compliant in the future.

Q4 FY24Q3 FY24Q4 FY23
Income tax provision$14.6$14.1$20.3
Effective income tax rate26.6%22.7%24.3%

The effective income tax rates are sensitive to the jurisdictional mix of our earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances.

The effective income tax rate increased in Q4 FY24, compared with Q3 FY24, primarily due to changes in the period-to-period mix of jurisdictional earnings as well as an increase in foreign tax as compared to the
prior quarter. The effective income tax rate increase in Q4 FY24, as compared with Q4 FY23, is primarily due to changes in the jurisdictional mix of earnings as well as an increase in foreign tax as compared to the prior year.

FY24FY23
Income tax provision$63.6$70.3
Effective income tax rate25.7%26.0%

31

Table of Contents

The decrease in the effective income tax rate on a full-year basis in FY24, compared with FY23, is primarily due to changes in the jurisdictional mix of earnings.  We consider all available evidence when
evaluating the potential future realization of deferred tax assets, and when, based on the weight of all available evidence, we determine that it is more likely than not that some portion or all of our deferred tax assets will not be
realized, we reduce our deferred tax assets by a valuation allowance. We also regularly assess the potential outcomes of ongoing and future tax examinations and, accordingly, have recorded accruals for such contingencies. Included in the
balance of unrecognized tax benefits as of October 31, 2024 and October 31, 2023, are $14.7 million and $8.9 million respectively, recorded in Other liabilities in the consolidated balance sheets
that, if recognized, would impact the effective tax rates.  The October 31, 2024 valuation allowance was reduced by $(2.0) million dollars which was offset by additional FIN 48 reserve of $5.8 million.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $6.4 million in Q4 FY24, compared with $13.8 million in Q3 FY24; the decrease was the result of a net decrease in the net incomes of our joint venture
operations. Net income attributable to noncontrolling interests decreased by $12.1 million in Q4 FY24 from Q4 FY23, and by $21.0 million in YTD FY24 from YTD FY23, as a result of decreased net income at both our Taiwan-based and China-based
IC facilities.

Liquidity and Capital Resources

Cash and cash equivalents was $598.5 million and $499.3 million as of October 31, 2024, and October 31, 2023, respectively. As of October 31, 2024, total cash and cash equivalents included $562.1 million held
by foreign subsidiaries. In addition, we currently have $42.2 million in short-term investments and RMB 200 million (approximately $28.1 million) of borrowing capacity in China to support local operations. See Note 8 – Debt to the consolidated financial statements for additional information on our outstanding debt and currently available financing. Our primary sources of liquidity are our cash on hand and cash we
generate from operations.

We continually evaluate alternatives for efficiently funding our capital expenditures and ongoing operations. These reviews may result in our engagement in a variety of investing and financing transactions, in
the transfer of cash among subsidiaries, and/or the repatriation of cash to the U.S. The transfer of funds among subsidiaries could be subject to foreign withholding taxes; in certain jurisdictions, repatriation of these funds to the U.S.
may subject them to U.S. state income taxes and/or local country withholding taxes. We believe that our liquidity, including available financing, is sufficient to meet our requirements through the next twelve months and thereafter for the
foreseeable future. Through the utilization of our existing liquidity, cash we generate from operations and short-term investments, we plan to continue to invest in our business, with our investments targeted to align with our customers’
technology road maps. In addition, we stand ready to invest in mergers, acquisitions, or strategic partnerships, should a suitable opportunity arise.

We estimate capital expenditures for our fiscal year 2025 will be approximately $200 million; these investments will be targeted towards high-end and mainstream “point” tools that will increase our operating
capacity and efficiency and enable us to support our customers’ near-term demands. As of October 31, 2024, we had outstanding capital commitments of approximately $105.4 million and accrued liabilities related to capital equipment purchases
of approximately $6.7 million. Although payment timing could vary, primarily as a result of the timing of tool delivery, installation and testing, we currently estimate that we will fund $98.1 million of our total $112.1 million committed
and recognized obligations for capital expenditures over the next twelve months. Please refer to Notes 11 - Leases and 16 – Commitments and Contingencies to
our consolidated financial statements for additional information on our lease liabilities and unrecognized commitments, respectively.

On August 28, 2024, the Board of Directors authorized an increase to the Company’s existing share repurchase program from the remaining $31.7 million up to $100 million. As of October 31, 2024, there was $100 million remaining under that authorization.
Depending on market conditions, we may utilize some or the entire remaining approved amount to reacquire additional shares.

As discussed in Note 6 – PDMCX Joint Venture of our consolidated financial statements, DNP, the noncontrolling interest in our China-based joint venture has, under
certain circumstances, the right to put its interest in the joint venture to Photronics, or to purchase our interest in the joint venture. Under all such circumstances, the sale of DNP’s interest would be at its ownership percentage of the
joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. As of the date of issuance of this report, DNP had not indicated its intention to exercise this right. As
of October 31, 2024, Photronics and DNP each had net investments in this joint venture of approximately $140.6 million.

32

Table of Contents

Cash Flows

Year Ended
October 31, 2024October 31, 2023October 31, 2022
Net cash provided by operating activities$261.4$302.2$275.2
Net cash used in investing activities$(156.5)$(101.5)$(147.8)
Net cash used in financing activities$(7.7)$(18.5)$(38.7)

Operating Activities: Net cash provided by operating activities reflects net income adjusted for certain non-cash
items, including depreciation and amortization, share-based compensation, and the effects of changes in operating assets and liabilities. Net cash provided by operating activities decreased by $40.8 million

in FY24, compared with FY23, primarily due to decreased net income and net cash-favorable changes in working capital, predominantly in Asia.

Investing Activities:  Net cash flows used in investing activities increased by $55.0 million in FY24, compared to FY23, primarily driven by an increase of
purchases of short-term investments of $80.4 million.  This was partially offset by an increase in proceeds from the maturity of short-term investments of $25.3 million.

Financing Activities: Net cash used in financing activities decreased by $10.8 million in FY24, compared to FY23.  This was driven by a decrease in repayments
of debt of $11.8 million

Our cash, cash equivalents, and restricted cash balances were positively impacted by changes in foreign currency exchange rates in FY24 of $2.1 million.

Non-GAAP Financial Measures

Non-GAAP Net Income attributable to Photronics, Inc. shareholders and non-GAAP diluted earnings per share are “non-GAAP financial measures” as such term is defined by Regulation G of the Securities and
Exchange Commission, and may differ from similarly named non-GAAP financial measures used by other companies. The financial tables below reconcile Photronics, Inc. financial results under GAAP to non-GAAP financial information. We believe
these non-GAAP financial measures that exclude certain items are useful for analysts and investors to evaluate our on-going performance because they enable a more meaningful comparison of historical results of our core business. These
non-GAAP metrics are not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss), Net income (loss) per share, or any other measure of consolidated results under U.S.
GAAP. The items excluded from these non-GAAP metrics, but included in the calculation of their closest GAAP equivalent, are significant components of the condensed consolidated statement of income and must be considered in performing a
comprehensive assessment of overall financial performance.

The following table reconciles GAAP to Non-GAAP Income for the indicated periods. The columns may not foot due to rounding.

33

Table of Contents

Three Months endedYear ended
Oct 31, 2024July 28, 2024Oct 31, 2023Oct 31, 2024Oct 31, 2023Oct 31, 2022
Reconciliation of GAAP to Non-GAAP Net Income:
GAAP Net Income attributable to Photronics, Inc. shareholders$33,869$34,388$44,611$130,688$125,485$118,786
FX loss (gain)7,758(4,068)(13,234)(2,168)(2,466)(27,344)
Estimated tax effects of above(1,936)9143,4374773175,933
Estimated noncontrolling interest effects of above(2,637)6812,431(1,407)2,6764,275
Non-GAAP Net Income attributable to Photronics, Inc. shareholders$37,054$31,915$37,245$127,590$126,012$101,650
Weighted-average number of common shares outstanding - Diluted62,45662,41462,06762,39161,75561,189
Reconciliation of GAAP to Non-GAAP EPS:
GAAP diluted earnings per share$0.54$0.55$0.72$2.09$2.03$1.94
Effects of the above adjustments0.05(0.04)(0.12)(0.04)0.01(0.28)
Non-GAAP diluted earnings per share$0.59$0.51$0.60$2.05$2.04$1.66

Business Outlook

Our current business outlook and guidance was provided in our Full Year and Fourth Quarter Fiscal 2024 Results earnings call, and related slide deck. These can be accessed in the investor section of our
website - www.photronics.com.

Our future results of operations and the other forward-looking statements contained in this filing and in our “Full Year and Fourth Quarter Fiscal 2024 Results” earnings call and presentation involve a number
of risks and uncertainties, some of which are discussed in Part I, Item 1A of this report. A number of other unforeseeable factors could cause actual results to differ materially from our expectations.

Critical Accounting Estimates

Our consolidated financial statements are based on the selection and application of accounting policies, which require management to make significant estimates and assumptions. We believe the following to be
the more critical areas that require judgment when applying our accounting policies:

Column 1Column 2Column 3
Revenue Recognition: The application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates, including the determination of whether we should recognize revenue as we perform or upon the completion of our performance, as these determinations impact the timing and amount of our reported revenue and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to recognize revenue, as well as the measurement of our progress towards satisfying our performance obligations, which determine the amount of revenue we are entitled to recognize.
Column 1Column 2Column 3
Property, Plant and Equipment: Significant judgment and assumptions are employed when we establish the estimated useful lives of asset classes, and determine when depreciation should commence for individual assets, as these determinations can significantly impact our gross margin and research and development expenses. Significant judgment would also be employed when events or changes in circumstances indicate that the carrying amount of a group of assets may not be recoverable, as the recoverability assessment requires us to forecast future cash flows related to these assets; this evaluation can significantly impact our gross margin and operating expense.
Column 1Column 2Column 3
Leases: Significant judgment is applied in the determination of whether an arrangement is, or contains, a lease and, in certain instances, whether the lease should be classified as an operating lease or a finance lease, which can impact the timing and classification of lease costs.
Column 1Column 2Column 3
Contingencies: We are subject to the possibility of losses from various contingencies. Significant judgment is necessary to estimate the probability and amount of a loss, if any, from such contingencies. An accrual is made when it is probable that a liability has been incurred or an asset has been impaired and the amount of loss can be reasonably estimated. Changes in estimates related to, and resolutions of, contingencies may have a material impact on our financial performance.

34

Table of Contents

Column 1Column 2Column 3
Income Taxes: Our annual tax rate is determined based on our income and the jurisdictions where it is earned, statutory tax rates, and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Also inherent in determining our annual tax rate are judgments and assumptions regarding the recoverability of certain deferred tax assets, and our ability to uphold certain tax positions. We are subject to complex tax laws, in the U.S. and numerous foreign jurisdictions, and the manner in which they apply can be open to interpretation. Realization of deferred tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction in future periods, which involves business plans, planning opportunities, and expectations about future outcomes. Our assessment relies on estimates and assumptions and may involve a series of complex judgments about future events.

There are a number of estimates and assumptions inherent in calculating the various components of our tax provision. Future events such as changes in tax legislation, geographic mix of
earnings, findings in tax audits, and earnings repatriation plans could have an impact on those estimates and our effective tax rate.

Effect of Recent Accounting Pronouncements

See Note 1 to our consolidated financial statements of this report for recent accounting pronouncements that may affect our financial reporting.

35

Table of Contents

FY 2023 10-K MD&A

SEC filing source: 0001140361-23-059254.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2023-12-26. Report date: 2023-10-31.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

We sell substantially all of our photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance electronic
products such as virtual reality/augmented reality advanced IC packages, photonics, micro-electronic mechanical systems, and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new
semiconductor and display designs and applications, particularly as they relate to the semiconductor industry's migration to more advanced product innovation, design methodologies, and fabrication processes. The demand for photomasks primarily
depends on design activity rather than sales volumes from products manufactured using semiconductor manufacturing technologies. Consequently, an increase in semiconductor or display sales does not necessarily result in a corresponding increase in
photomask sales. However, the reduced use of application-specific ICs, reductions in design complexities, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new
semiconductor or display designs could reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. Advances in semiconductor, display, and photomask design and production methods that shift the burden of achieving
device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronics industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These negative trends have been
characterized by, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC
photomasks and two to three weeks of backlog for FPD photomasks. However, the demand for some IC photomasks can extend longer than the traditional time period; thus, for some products, our backlog can expand to as long as two to three months.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices,
mobile communications, and computing solutions. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we believe that
such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent
upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

We are focused on improving our competitiveness by advancing our technology and reducing costs and, in connection therewith, have invested and plan to continue to invest in manufacturing equipment to serve both the
high-end photomask and trailing-edge markets. As we face challenges that require us to make significant improvements in our competitiveness, we continue to evaluate further cost reduction initiatives.

State-of-the-art production for semiconductor masks is considered to be 28 nanometer and smaller for ICs and Generation 10.5+ and AMOLED and LTPS display-based process technologies for FPDs. However, 32 nanometer and
above geometries for semiconductors and Generation 8 and below (excluding AMOLED and LTPS) process technologies for displays constitute the majority of designs currently being fabricated in volume. At these geometries and various high-end nodes, we
can produce full lines of photomasks, and there is no significant technology employed by our competitors that is not available to us. We expect advanced-generation designs to continue to move to production throughout fiscal 2024, and we believe we
are well positioned to service an increasing volume of this business as a result of our investments in manufacturing processes and technology in the regions where our customers are located.

23

Table of  Contents

The photomask industry has been, and is expected to continue to be characterized by technological change and evolving industry standards. In order to remain competitive, we will be required to continually anticipate,
respond to, and utilize changing technologies. In particular, we believe that, as semiconductor geometries continue to become smaller, and display designs become larger or otherwise more advanced, we will be required to manufacture even more
complex optically-enhanced reticles, including optical proximity correction, phase-shift and EUV photomasks. Additionally, demand for photomasks has been, and could in the future be, adversely affected by changes in high-performance electronics
fabrication methods that affect the type or quantity of photomasks used, such as changes in semiconductor demand that favor field-programmable gate arrays and other semiconductor designs that replace application-specific ICs, or the use of certain
chip-stacking methodologies that lessen the emphasis on conventional lithography technology. Furthermore, increased market acceptance of alternative methods of transferring circuit designs onto semiconductor wafers could reduce or eliminate the
need for photomasks in the production of semiconductors. As of the end of 2023, one alternative method, direct-write lithography, has not been proven to be a commercially viable alternative to photomasks, as it is considered to be too slow for
high-volume semiconductor wafer production, and we have not experienced a significant loss of revenue as a result of this or other alternative semiconductor design methodologies. However, should direct-write lithography or any other alternative
method of transferring IC designs to semiconductor wafers without the use of photomasks achieve market acceptance, and we do not anticipate, respond to, or utilize these or other changing technologies due to resource, technological, or other
constraints, our business and results of operations could be materially adversely affected.

Our revenues have benefitted, and our costs, including depreciation, have been affected by the increased demand for high-end-technology photomasks that require more advanced manufacturing capabilities, but generally
command higher ASPs. Our capital expenditure payments were $131.3 million, $112.3 million and $109.1 million in 2023, 2022 and 2021, respectively. Nonetheless, we intend to continue to make the required investments to support the technological
requirements of our customers that we believe will continue to enable our growth. In support of this effort, we expect capital expenditure payments to be approximately $140 million in fiscal year 2024.

The manufacture of photomasks for use in fabricating ICs, FPDs, and other related products built using comparable photomask-based process technologies has been, and continues to be, capital intensive. Our employees and
our integrated global manufacturing network represent a significant portion of our fixed operating cost base. Should our revenue decrease as a result of a decrease in design releases from our customers, we may have excess or underutilized
production capacity, which could significantly impact our operating margins, or result in write-offs from asset impairments.

24

Table of  Contents

Results of Operations

The following tables present selected operating information expressed as a percentage of revenue. The columns may not foot due to rounding.

Three Months Ended
October 31, 2023July 30, 2023October 31, 2022
Revenue100.0%100.0%100.0%
Cost of goods sold62.761.361.8
Gross profit37.338.738.2
Selling, general and administrative expenses7.48.07.5
Research and development expenses1.51.61.9
Operating income28.5%29.1%28.8%
Non-operating income (expense), net8.2-0.45.1
Income before income tax provision36.728.733.9
Income tax provision8.97.27.6
Net income27.821.526.3
Net income attributable to noncontrolling interests8.29.58.7
Net income attributable to Photronics, Inc. shareholders19.6%12.0%17.6%
Year Ended
October 31, 2023October 31, 2022October 31, 2021
Revenue100.0%100.0%100.0%
Cost of goods sold62.364.374.8
Gross profit37.735.725.2
Selling, general and administrative expenses7.87.88.7
Research and development expenses1.52.22.8
Other operating income, net0.00.00.5
Operating income28.4%25.7%14.2%
Non-operating income (expense), net1.93.31.1
Income before income tax provision30.329.015.4
Income tax provision7.97.33.5
Net income22.421.711.9
Net income attributable to noncontrolling interests8.37.33.5
Net income attributable to Photronics, Inc. shareholders14.1%14.4%8.4%

25

Table of  Contents

Note: All the following tabular comparisons, unless otherwise indicated, are for the three months ended October 31, 2023 (Q4 FY23), July 30, 2023 (Q3 FY23) and October 31, 2022
(Q4 FY22), and for the fiscal years ended October 31, 2023 (YTD FY23) and October 31, 2022 (YTD FY22). Please refer to Part II, Item 7 of our 2022 Form 10-K for comparative discussion of our fiscal years ended October 31, 2022, and October 31,
2021. The tables in this item may not foot due to rounding.

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first quarter of our fiscal year by the North American,
European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

The following tables present changes in revenue disaggregated by product type and geographic origin, in Q4 FY23 and YTD FY23 from revenue in prior reporting periods.

Quarterly Changes in Revenue by Product Type

Q4 FY23 compared with Q3 FY23Q4 FY23 compared with Q4 FY22
Revenue inIncreasePercentIncreasePercent
Q4 FY23(Decrease)Change(Decrease)Change
IC
High-end *$57.7$12.427.4%$13.430.2%
Mainstream106.8(11.0)(9.3)%(5.1)(4.5)%
Total IC$164.5$1.40.8%$8.35.3%
FPD
High-end *$53.3$3.36.6%$9.922.8%
Mainstream9.7(1.4)(12.5)%(0.9)(8.9)%
Total FPD$63.0$1.93.1%$9.016.5%
Total Revenue$227.5$3.31.5%$17.28.2%
Column 1Column 2
*High-end photomasks typically have higher ASPs than mainstream products.

Quarterly Changes in Revenue by Geographic Origin**

Q4 FY23 compared with Q3 FY23Q4 FY23 compared with Q4 FY22
Revenue inIncreasePercentIncreasePercent
Q4 FY23(Decrease)Change(Decrease)Change
Taiwan$79.3$(2.3)(2.8)%$3.03.9%
China59.2(2.9)(4.6)%6.812.9%
Korea42.21.43.3%4.211.2%
United States36.87.123.9%2.88.2%
Europe9.3(0.2)(2.2)%0.33.0%
Other0.70.234.4%0.124.7%
Total revenue$227.5$3.31.5%$17.28.2%
Column 1Column 2
**This table disaggregates revenue by the location in which it was earned.

Revenue in Q4 FY23 of $227.5 million represented an increase of 1.5% compared with Q3 FY23, and an increase of 8.2% from Q4 FY22.

26

Table of  Contents

Overall IC revenue increased 0.8 % from Q3 FY23, and increased 5.3% from Q4 FY22 due to stronger high-end foundry and logic demand in Asia. IC mainstream decreased in Q4 FY23 by 9.3% from Q3 FY23, and 4.5% from Q4 FY22
primarily the result of reduced mainstream demand in Asia.

FPD revenue increased 3.1% and 16.5% in Q4 FY23, compared, respectively, with Q3 FY23 and Q4 FY22. The increases were caused by continued strong AMOLED demand in mobile display during Q4 FY23. Revenue from mainstream
products decreased 12.5% from Q3 FY23 as more production capacity was dedicated to meet strong high-end demand.

Year-over-Year Changes in Revenue by Product Type

YTD FY23 compared with YTD FY22
Revenue inIncreasePercent
YTD FY23(Decrease)Change
IC
High-end *$195.0$(0.4)(0.2)%
Mainstream456.358.614.7%
Total IC651.3$58.39.8%
FPD
High-end *200.8$13.97.4%
Mainstream40.0(4.6)(10.3)%
Total FPD240.8$9.34.0%
Total Revenue892.1$67.58.2%
Column 1Column 2
*High-end photomasks typically have higher ASPs than mainstream photomasks.

Year-over-Year Changes in Revenue by Geographic Origin**

YTD FY23 compared with YTD FY22
Revenue inIncreasePercent
YTD FY23(Decrease)Change
Taiwan$316.9$25.58.8%
China245.432.815.4%
Korea162.26.13.9%
United States128.92.72.1%
Europe36.60.20.5%
Other2.10.313.5%
$892.1$67.58.2%
Column 1Column 2
**This table disaggregates revenue by the location in which it was earned.

Revenue in YTD FY23 of $892.1 million surpassed our prior record revenue set in YTD FY22 by $67.5 million, or 8.2%. IC revenue increased by 9.8%, due to strong demand for mainstream products
earlier in the year. FPD revenue increased by 4.0%, driven by a 7.4% increase in revenue from high-end products due to increased AMOLED demand in mobile displays, which offset decreased mainstream resulting from shifting capacity to meet strong
high-end demand. We believe that strong demand for AMOLED photomasks will continue, as expected technology advances drives increasing overall demand for higher-value masks.

27

Table of  Contents

Gross Margin

PercentPercent
Q4 FY23Q3 FY23ChangeQ4 FY22Change
Gross profit$84.9$86.8(2.2)%$80.35.7%
Gross margin37.3%38.7%38.2%

Gross margin was 37.3% for Q4 FY23, representing a slight decrease from the Q3 FY23 gross margin of 38.7%, as increase in revenue of 1.5% was offset by increased material costs of 4.2%, or 69 basis points as a
percentage of revenue. Labor costs increased 4.5%, or 30 basis points as a percentage of revenue, due to increased costs in some locations. Equipment and other overhead costs increased 3.0%, or 41 basis points as a percentage of revenue, with
increased equipment maintenance costs, partially offset by lower outsourced manufacturing costs, most significantly contributing to the net cost increase.

Gross margin decreased by 0.9 percentage points in Q4 FY23, from Q4 FY22, primarily as a result of the increase in material costs as a percentage of revenue from the prior year quarter. Equipment and other overhead
costs increased 9.7%, or 37 basis points, as a percentage of revenue. Increased depreciation expense, utilities expenses, and outsourced manufacturing costs, which were partially offset by decreased equipment maintenance costs, were the primary
contributors to the overall increase.

Percent
YTD FY23YTD FY22Change
Gross profit$336.2$294.214.3%
Gross margin37.7%35.7%

Gross margin increased by 2.0 percentage points in YTD FY23, from YTD FY22, primarily as a result of the increase in revenue from the prior year period, offset somewhat by the
following net cost increases: Material costs increased 2.8% from the prior year period, but decreased 129 basis points as a percentage of revenue. Labor costs increased 10.3% from the prior year, and increased 30 basis points as a percentage of
revenue, primarily due to increased labor costs in Asia. Equipment and other overhead costs increased by 4.5% but decreased 95 basis points as a percentage of revenue, with increased utilities, equipment
service contract costs, and less transfer of research and development cost from cost of goods sold to research and development expense, as well as increases in computer software costs, offset by decreased importation costs most significantly
contributing to the overall cost increase.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $16.7 million in Q4 FY23, compared with $18.0 million in Q3 FY23, and $15.7 million in Q4 FY22. The decrease from Q3 FY23 was primarily the result of decreased
compensation and related expenses of $1.5 million offset partially by increased insurance expenses and outside services of $0.1 million and $0.1 million, respectively.  The increase from the prior year quarter was primarily the result of increased
compensation and related expenses of $1.0 million and increased insurance expenses of $0.2 million.  Selling, general and administrative expenses increased $5.5 million to $69.5 million in YTD FY23, from $64.0 million in YTD FY22, primarily due to
an increase in compensation and related expenses, professional fees, travel and entertainment and insurance expenses in the respective amounts of $4.1 million, $1.2 million, $0.4 million and $0.3 million.

Research and Development Expenses

Research and development expenses, which primarily consist of development and qualification efforts related to process technologies for high-end IC and FPD applications, decreased $0.1 million to
$3.4 million in Q4 FY23, from Q3 FY23; the decrease was primarily caused by a decline in development activities in Asia. Research and development expenses in Q4 FY23 decreased by $0.7 million from Q4 FY22 as a result of decreased development
activities in the U.S. and Asia. On a year-to-date basis, research and development expenses decreased $4.7 million, to $13.7 million, primarily due to decreased development activities in the U.S.

28

Table of  Contents

Non-Operating Income (Expense)

Q4 FY23Q3 FY23Q4 FY22
Foreign currency transactions impact, net$13.2$(4.5)$10.4
Interest expense, net(0.1)(0.1)(0.4)
Interest income and other income, net5.63.70.8
Non-operating income (expense), net$18.7$(0.9)$10.8

Non-operating income (expense) increased in Q4 FY23 from Q3 FY23 by $19.6 million, primarily due to foreign currency impacts, driven by favorable movements of the South Korean
won, the New Taiwan dollar, RMB dollar against the U.S. dollar offsetting unfavorable movements of the Singapore dollar against the U.S. dollar. Non-operating income (expense) increased from Q4 FY22, by $7.9 million,

primarily due to higher interest and investment income earned on our cash balances, in addition to foreign currency transactions impact.

YTD FY23YTD FY22
Foreign currency transactions impact, net$2.5$27.3
Interest expense, net(0.4)(1.9)
Interest income and other income, net14.81.7
Non-operating income (expense), net$16.9$27.2

Non-operating income (expense) decreased $10.3 million in full year FY23, compared with full year FY22, due to foreign currency transactions, driven by unfavorable movements of the South Korean won, the New Taiwan
dollar, and the Singapore dollar offsetting favorable movements of the RMB against the U.S. dollar, partially offset by increased interest income in the current year resulting from higher average cash, cash equivalents and short-term investments
balances in FY23, compared with FY22 and lower interest expense, net of subsidies, due to receiving a lower amount of interest subsidies on our China-based debt in FY23, the effect of which was partially mitigated by lower average interest-bearing
debt balance in FY23 than in the prior year.  The columns presented above may not foot due to rounding.

Income Tax Provision

On December 15, 2022, the European Union (EU) Member States formally adopted the EU’s Pillar Two Directive, which generally provides for a minimum
effective tax rate of 15%, as established by the Organization for Economic Co-operation and Development (OECD) Pillar Two Framework. The EU effective dates are January 1, 2024, and January 1, 2025, for different aspects of the directive. A
significant number of other countries are expected to also implement similar legislation with varying effective dates in the future. The Company is continuing to evaluate the potential impact on future periods of the Pillar Two Framework, pending
legislative adoption by additional individual countries.

Q4 FY23Q3 FY23Q4 FY22
Income tax provision$20.3$16.1$16.1
Effective income tax rate24.3%25.0%22.5%

The effective income tax rates are sensitive to the jurisdictional mix of our earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances where the tax benefits
of losses are not available.

The effective income tax rate decreased slightly in Q4 FY23, compared with Q3 FY23, primarily due to changes in the period-to-period mix of jurisdictional earnings. The effective income tax rate increase in Q4 FY23, as
compared with Q4 FY22, is primarily due to changes in the jurisdictional mix of earnings as well as an increase in foreign tax as compared to the prior year.

FY23FY22
Income tax provision$70.3$59.8
Effective income tax rate26.0%25.0%

29

Table of  Contents

The increase in the effective income tax rate on a full-year basis in FY23, compared with FY22, is primarily due to an increase of unremitted earnings tax in a non-US jurisdiction, as well as changes in the
jurisdictional mix of earnings. We consider all available evidence when evaluating the potential future realization of deferred tax assets, and when, based on the weight of all available evidence, we determine that it is more likely than not that
some portion or all of our deferred tax assets will not be realized, we reduce our deferred tax assets by a valuation allowance. We also regularly assess the potential outcomes of ongoing and future tax examinations and, accordingly, have recorded
accruals for such contingencies. Included in the balance of unrecognized tax benefits as of October 31, 2023 and October 31, 2022, are $8.9 million and $5.6 million respectively, recorded in Other liabilities
in the consolidated balance sheets that, if recognized, would impact the effective tax rates.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $18.5 million in Q4 FY23, compared with $21.3 million in Q3 FY23; the decrease was the result of a net decrease in the net
incomes of our joint venture operations. Net income attributable to noncontrolling interests increased by $0.3 million in Q4 FY23 from Q4 FY22, and by $13.7 million in
YTD FY23 from YTD FY22, as a result of increased net income at both our Taiwan-based and China-based IC facilities.

Liquidity and Capital Resources

Cash and cash equivalents was $499.3 million and $319.7 million as of October 31, 2023, and October 31, 2022, respectively. As of the most recent balance sheet date, total cash
and cash equivalents included $473.2 million held by foreign subsidiaries. Net Cash, a non-GAAP financial measure as defined and discussed in the Non-GAAP Financial Measures section below, was $474.7 million
and $277.3 million as of October 31, 2023, and October 31, 2022, respectively. Our primary sources of liquidity are our cash on hand and cash we generate from operations.

We continually evaluate alternatives for efficiently funding our capital expenditures and ongoing operations. These reviews may result in our engagement in a variety of investing and financing transactions, in the
transfer of cash among subsidiaries, and/or the repatriation of cash to the U.S. The transfer of funds among subsidiaries could be subject to foreign withholding taxes; in certain jurisdictions, repatriation of these funds to the U.S. may subject
them to U.S. state income taxes and/or local country withholding taxes. We believe that our liquidity, including available financing, is sufficient to meet our requirements through the next twelve months and thereafter for the foreseeable future.
Through the utilization of our existing liquidity, cash we generate from operations and short-term investments, we plan to continue to invest in our business, with our investments targeted to align with our customers’ technology road maps. In
addition, we stand ready to invest in mergers, acquisitions, or strategic partnerships, should a suitable opportunity arise.

We estimate capital expenditures for our fiscal year 2024 will be approximately $140 million; these investments will be targeted towards high-end and mainstream “point” tools
that will increase our operating capacity and efficiency, and enable us to support our customers’ near-term demands. As of October 31, 2023, we had outstanding capital commitments of approximately $106.8 million

and recognized liabilities related to capital equipment purchases of approximately $18.7 million. Although payment timing could vary, primarily as a result of the timing of tool delivery, installation and
testing, we currently estimate that we will fund $88.6 million of our total $125.5 million committed and recognized obligations for capital expenditures over the next
twelve months. Please refer to Notes 10 and 15 to our consolidated financial statements for additional information on our lease liabilities and unrecognized commitments, respectively.

In September 2020, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act. This authorization does
not obligate the Company to repurchase any dollar amount or number of shares of common stock. As of October 31, 2023, there was approximately $31.7 million remaining under that authorization. Depending on market conditions, we may utilize some or
the entire remaining approved amount to reacquire additional shares.

30

Table of  Contents

As discussed in Note 6 of our consolidated financial statements, DNP, the noncontrolling interest in our China-based joint venture has, under certain circumstances, the right to put its interest in the joint venture to
Photronics, or to purchase our interest in the joint venture. Under all such circumstances, the sale of DNP’s interest would be at its ownership percentage of the joint venture’s net book value, with closing to take place within three business days
of obtaining required approvals and clearance. As of the date of issuance of this report, DNP had not indicated its intention to exercise this right. As of October 31, 2023, Photronics and DNP each had net investments in this joint venture of
approximately $117.1 million.

Cash Flows

Year Ended
October 31, 2023October 31, 2022October 31, 2021
Net cash provided by operating activities$302.2$275.2$150.8
Net cash used in investing activities$(101.5)$(147.8)$(103.5)
Net cash used in financing activities$(18.5)$(38.7)$(53.9)

Operating Activities: Net cash provided by operating activities reflects net income adjusted for certain non-cash items, including depreciation and amortization,
share-based compensation, and the effects of changes in operating assets and liabilities. Net cash provided by operating activities increased by $27.0 million in FY23, compared with FY22, primarily due to
increased net income and net cash-favorable changes in working capital, predominantly in Asia.

Free Cash Flow, which is a non-GAAP financial measure as discussed in the “Non-GAAP Financial Measures” section below, increased by $8.0 million in FY23, compared with FY22, and
$121.2 million in FY22, compared with FY21, primarily due to increases in net cash provided by operating activities.

Investing Activities:  In FY23, net cash flows used in investing activities primarily consisted of purchases of $131.3 million
of property, plant and equipment. Net cash flows used in investing activities decreased by $46.2 million in FY23, compared with FY22, primarily as a result of $47.5 million in proceeds from the maturity of
available-for-sale debt securities.

Financing Activities: In FY23, net cash flows used in financing activities primarily consisted of debt repayments of $18.5 million. Net cash used in financing
activities decreased by $20.2 million in FY23, compared with FY22, primarily due to decreased repayments of debt of $47.0 million, offset by decreased contributions from noncontrolling interests of $25.0 million that occurred in FY22 but did not
repeat in FY23.

Our cash, cash equivalents, and restricted cash balances were negatively impacted by changes in foreign currency exchange rates in FY23 by $2.7 million.

Non-GAAP Financial Measures

Non-GAAP Non-operating (loss) income, Non-GAAP Income tax provision, Non-GAAP Noncontrolling interests, Non-GAAP Net Income attributable to Photronics, Inc. shareholders and non-GAAP earnings per share, Free Cash Flow,
and Net Cash are "non-GAAP financial measures" as such term is defined by the Securities and Exchange Commission and may differ from similarly named non-GAAP financial measures used by other companies. The financial tables below reconcile
Photronics, Inc. financial results under GAAP to non-GAAP financial information. We believe these non-GAAP financial measures that exclude certain items are useful for analysts and investors to evaluate our future on-going performance because they
enable a more meaningful comparison of our projected performance with our historical results. These non-GAAP metrics are not intended to represent funds available for our discretionary use and are not intended to represent, or be used as a
substitute for, net income attributable to Photronics, Inc. shareholders, diluted earnings per share, cash and cash equivalents, or cash flows from operations, as measured under GAAP. The items excluded from these non-GAAP metrics but included in
the calculation of their closest GAAP equivalent, are significant components of the consolidated statements of income, consolidated balance sheets and statement of cash flows and must be considered in performing a comprehensive assessment of
overall financial performance.

31

Table of  Contents

The following table reconciles GAAP to Non-GAAP Income at the balance sheet dates. The columns may not foot due to rounding.

Three Months endedYear ended
Oct 31,July 30,Oct 31,Oct 31,Oct 31,Oct 31,
202320232022202320222021
Reconciliation of GAAP to Non-GAAP Non-operating (loss) Income:
GAAP Non-operating (loss) income, net$18,660$(911)$10,797$16,896$27,167$7,452
FX (gain) loss(13,234)4,543(10,369)(2,466)(27,344)(7,972)
Non-GAAP Non-operating (loss) income, net$5,426$3,632$428$14,430$(177)$(520)
Reconciliation of GAAP to Non-GAAP Income tax provision:
GAAP Income tax provision$20,288$16,098$16,074$70,312$59,791$23,190
Estimated tax effects of FX (gain) loss3,437(1,193)2,5223175,9331,829
Non-GAAP Income tax provision$16,851$17,291$13,552$69,995$53,858$21,361
Reconciliation of GAAP to Non-GAAP Noncontrolling interests:
GAAP Noncontrolling interests$18,545$21,296$18,204$74,149$60,456$23,367
Estimated noncontrolling interest effects of above2,4311,3281,9902,6764,275(481)
Non-GAAP Noncontrolling interests$16,114$19,968$16,214$71,473$56,181$23,848
Reconciliation of GAAP to Non-GAAP Net Income:
GAAP Net Income$44,611$26,959$37,060$125,485$118,786$55,449
FX (gain) loss(13,234)4,543(10,369)(2,466)(27,344)(7,972)
Estimated tax effects of above3,437(1,193)2,5223175,9331,829
Estimated noncontrolling interest effects of above2,4311,3281,9902,6764,275(481)
Non-GAAP Net Income$37,245$31,637$31,203$126,012$101,650$48,825
Weighted-average number of common shares outstanding - Diluted62,06761,97461,37461,75561,18961,999
Reconciliation of GAAP to Non-GAAP EPS:
GAAP diluted earnings per share$0.72$0.44$0.60$2.03$1.94$0.89
Effects of the above adjustments(0.12)0.07(0.10)0.01(0.28)(0.10)
Non-GAAP diluted earnings per share$0.60$0.51$0.51$2.04$1.66$0.79

32

Table of  Contents

The following table reconciles Net cash provided by operating activities to Free Cash Flow for FY23, FY22, and FY21. The columns may not foot due to rounding. Prior year
amounts in the non-GAAP disclosure below have been recast to eliminate government incentives to conform to current year presentation.

FY23FY22FY21
Free Cash Flow
Net cash provided by operating activities$302.2$275.2$150.8
Purchases of property, plant and equipment(131.3)(112.3)(109.1)
Free cash flow$170.9$162.9$41.7

The following table reconciles Cash and cash equivalents to Net Cash at the balance sheet dates. The increase in Net Cash was primarily driven by an increase in Net cash provided by
operating activities, as discussed above. The columns may not foot due to rounding.

As of
October 31, 2023October 31, 2022
Net Cash
Cash, cash equivalents$499.3$319.7
Current portion of Long-term debt(6.6)(10.0)
Long-term debt(18.0)(32.3)
Net cash$474.7$277.4

Business Outlook

Our current business outlook and guidance was provided in our Full Year and Fourth Quarter Fiscal 2023 Results earnings call, and related slide deck. These can be accessed in the investor section of our website -
www.photronics.com.

Our future results of operations and the other forward-looking statements contained in this filing and in our “Full Year and Fourth Quarter Fiscal 2023 Results” earnings call
and presentation involve a number of risks and uncertainties, some of which are discussed in Part I, Item 1A of this report. A number of other unforeseeable factors could cause actual results to differ materially from our expectations.

Critical Accounting Estimates

Our consolidated financial statements are based on the selection and application of accounting policies, which require management to make significant estimates and assumptions. We believe the following to be the more
critical areas that require judgment when applying our accounting policies:

Column 1Column 2Column 3
Revenue Recognition: The application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates, including the determination of whether we should recognize revenues as we perform or upon the completion of our performance, as these determinations impact the timing and amount of our reported revenues and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to recognize revenue, as well as the measurement of our progress towards satisfying our performance obligations, which determine the amount of revenue we are entitled to recognize.

33

Table of  Contents

Column 1Column 2Column 3
Property, Plant and Equipment: Significant judgment and assumptions are employed when we establish the estimated useful lives of asset classes, and determine when depreciation should commence for individual assets, as these determinations can significantly impact our gross margin and research and development expenses. Significant judgment would also be employed when events or changes in circumstances indicate that the carrying amount of a group of assets may not be recoverable, as the recoverability assessment requires us to forecast future cash flows related to these assets; this evaluation can significantly impact our gross margin and operating expense.
Column 1Column 2Column 3
Leases: Significant judgment is applied in the determination of whether an arrangement is, or contains, a lease and, in certain instances, whether the lease should be classified as an operating lease or a finance lease, which can impact the timing and classification of lease costs.
Column 1Column 2Column 3
Contingencies: We are subject to the possibility of losses from various contingencies. Significant judgment is necessary to estimate the probability and amount of a loss, if any, from such contingencies. An accrual is made when it is probable that a liability has been incurred or an asset has been impaired and the amount of loss can be reasonably estimated. Changes in estimates related to, and resolutions of, contingencies may have a material impact on our financial performance.
Column 1Column 2Column 3
Income Taxes: Our annual tax rate is determined based on our income and the jurisdictions where it is earned, statutory tax rates, and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Also inherent in determining our annual tax rate are judgments and assumptions regarding the recoverability of certain deferred tax assets, and our ability to uphold certain tax positions. We are subject to complex tax laws, in the U.S. and numerous foreign jurisdictions, and the manner in which they apply can be open to interpretation. Realization of deferred tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction in future periods, which involves business plans, planning opportunities, and expectations about future outcomes. Our assessment relies on estimates and assumptions and may involve a series of complex judgments about future events.

There are a number of estimates and assumptions inherent in calculating the various components of our tax provision. Future events such as changes in tax legislation, geographic mix of earnings, findings in tax audits,
and earnings repatriation plans could have an impact on those estimates and our effective tax rate.

Please refer to Notes 1, 10, 13, and 15 to our consolidated financial statements for additional information related to these critical accounting estimates.

Effect of Recent Accounting Pronouncements

See Note 22 to our consolidated financial statements of this report for recent accounting pronouncements that may affect our financial reporting.

34

Table of  Contents

FY 2022 10-K MD&A

SEC filing source: 0001140361-22-046880.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2022-12-23. Report date: 2022-10-31.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

We sell substantially all of our photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance
electronic products such as photonics, micro-electronic mechanical systems, and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and display designs and
applications, particularly as they relate to the semiconductor industry’s migration to more advanced product innovation, design methodologies, and fabrication processes. The demand for photomasks primarily depends on design activity rather than
sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or display sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of
application-specific ICs, reductions in design complexities, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or display designs could reduce demand
for photomasks ‒ even if the demand for semiconductors and FPDs increases. Advances in semiconductor, display, and photomask design and production methods that shift the burden of achieving device performance away from lithography could also
reduce the demand for photomasks. Historically, the microelectronics industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These negative trends have been characterized by, among other things, diminished
product demand, excess production capacity, and accelerated erosion of selling prices with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for
IC photomasks and two to three weeks of backlog for FPD photomasks. However, the demand for some IC photomasks has recently expanded beyond the industry’s capacity to supply them within the traditional time period; thus, for some products, our
backlog can expand to as long as two to three months.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices,
mobile communications, and computing solutions. While we cannot predict the timing of the industry’s transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we believe that
such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is
dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

We are focused on improving our competitiveness by advancing our technology and reducing costs and, in connection therewith, have invested and plan to continue to invest in manufacturing equipment to serve both the
high-end photomask and trailing-edge markets. As we face challenges that require us to make significant improvements in our competitiveness, we continue to evaluate further cost reduction initiatives.

State-of-the-art production for semiconductor masks is considered to be 28 nanometer and smaller for ICs and Generation 10.5+ and AMOLED and LTPS display-based process technologies for FPDs. However, 32 nanometer
and above geometries for semiconductors and Generation 8 and below (excluding AMOLED and LTPS) process technologies for displays constitute the majority of designs currently being fabricated in volume. At these geometries, we can produce full
lines of photomasks, and there is no significant technology employed by our competitors that is not available to us. We expect advanced-generation designs to continue to move to production throughout fiscal 2023, and we believe we are well
positioned to service an increasing volume of this business as a result of our investments in manufacturing processes and technology in the regions where our customers are located.

22

Table of Contents

The photomask industry has been, and is expected to continue to be characterized by technological change and evolving industry standards. In order to remain competitive, we will be required to continually
anticipate, respond to, and utilize changing technologies. In particular, we believe that, as semiconductor geometries continue to become smaller, and display designs become larger or otherwise more advanced, we will be required to manufacture
even more complex optically-enhanced reticles, including optical proximity correction and phase-shift photomasks. Additionally, demand for photomasks has been, and could in the future be, adversely affected by changes in high-performance
electronics fabrication methods that affect the type or quantity of photomasks used, such as changes in semiconductor demand that favor field-programmable gate arrays and other semiconductor designs that replace application-specific ICs, or the
use of certain chip-stacking methodologies that lessen the emphasis on conventional lithography technology. Furthermore, increased market acceptance of alternative methods of transferring circuit designs onto semiconductor wafers could reduce
or eliminate the need for photomasks in the production of semiconductors. As of the end of 2022, one alternative method, direct-write lithography, has not been proven to be a commercially viable alternative to photomasks, as it is considered to
be too slow for high-volume semiconductor wafer production, and we have not experienced a significant loss of revenue as a result of this or other alternative semiconductor design methodologies. However, should direct-write lithography or any
other alternative method of transferring IC designs to semiconductor wafers without the use of photomasks achieve market acceptance, and we do not anticipate, respond to, or utilize these or other changing technologies due to resource,
technological, or other constraints, our business and results of operations could be materially adversely affected.

Both our revenues and costs have been affected by the increased demand for high-end-technology photomasks that require more advanced manufacturing capabilities, but generally command higher ASPs. Our capital
expenditure payments were $112.3 million, $109.1 million and $70.8 million in 2022, 2021 and 2020, respectively, and the depreciation on these investments has significantly contributed to our cost of goods sold. Nonetheless, we intend to
continue to make the required investments to support the technological demands of our customers that we believe will position us for future growth. In support of this effort, we expect capital expenditure payments to be approximately $130
million in fiscal year 2023.

The manufacture of photomasks for use in fabricating ICs, FPDs, and other related products built using comparable photomask-based process technologies has been, and continues to be, capital intensive. Our employees
and our integrated global manufacturing network represent a significant portion of our fixed operating cost base. Should our revenue decrease as a result of a decrease in design releases from our customers, we may have excess or underutilized
production capacity, which could significantly impact our operating margins, or result in write-offs from asset impairments.

Recent Developments

In the second quarter of 2021, under an MLA which we entered into effective October 2020, we entered into a five-year $7.2 million finance lease for a high-end inspection tool. Monthly payments on the lease, which
commenced in February 2021, are $0.1 million per month. Upon the payment of the fiftieth monthly payment and prior to payment of the fifty-first monthly payment, we may exercise an early buyout option to purchase the tool for $2.4 million. If
we do not exercise the early buyout option, then at the end of the five-year lease term, the lease shall continue to renew on a month-to-month basis at the same rental terms; at our option, after the original term or any renewal periods, we may
return the tool, elect to extend the lease, or purchase the tool at its fair market value. Since we are reasonably certain that we will exercise the early buyout option, our lease liability reflects such exercise and we have classified the
lease as a finance lease. The interest rate implicit in the lease is 1.08%.

In the first quarter of 2021, under an MLA which we entered into effective July 2019, we entered into a five-year $35.5 million finance lease for a high-end lithography tool. Monthly payments on the lease, which
commenced in January 2021, increased from $0.04 million after the first three months to $0.6 million for the following nine months, followed by forty-eight monthly payments of $0.5 million. As of the due date of the forty-eighth monthly
payment, we may exercise an early buyout option to purchase the tool for $14.1 million. If we do not exercise the early buyout option, then at the end of the five-year lease term, at our option, we may return the tool, elect to extend the lease
term for a period and a lease payment to be agreed with lessor at the time, or purchase the tool for its then-fair market value as determined by the lessor. Since we are reasonably certain that we will exercise the early buyout option, our
lease liability reflects such exercise and we have classified the lease as a finance lease. The interest rate implicit in the lease is 1.58%. The lease agreement incorporates the covenants included in our Corporate Credit Agreement, which are
detailed in Note 6 to our consolidated financial statements in Part II, Item 8 of this report, and includes a cross-default provision for any agreement or instrument with an outstanding, committed balance greater than $5.0 million in which we
are the indebted party.

In the fourth quarter of 2020, we entered into a MLA with a financing entity for the lease of an inspection tool with a maximum value of $10 million.  The tool was delivered during the fourth
quarter of 2020, and the financing entity made a progress payment to the vendor of $6.5 million in the first quarter of 2021. The progress payment accrued interest at 1.56% payable monthly until the final payment for the tool was made in the
second quarter of 2021, at which point the $7.2 million lease described above began.

23

Table of Contents

In the fourth quarter of 2020, our Hefei, China, facility was approved to borrow 200 million RMB from the China Construction Bank Corporation. This credit facility was subject to annual reviews and extension; the
most recent extension allowing us to borrow additional funds was expired in August 2022. The loan proceeds were used to fund purchases of two lithography tools at the Hefei facility. As of October 31, 2021, we had borrowed 135.7 million RMB
($21.2 million) against this approval (all of which was then outstanding), and 64.3 million RMB ($10.1 million) remained available to borrow; we repaid the entire outstanding balance in 2022, and did not apply to extend the agreement. The
interest rate on the loan was variable and based on the RMB Loan Prime Rate of the National Interbank Funding Center. The borrowings were secured by the Hefei facility, its related land use right, and certain manufacturing equipment. The Hefei
Equipment Loan was subject to covenants and provisions, certain of which relate to the assets pledged as security for the loan, including covenants for the ratio of total liabilities to total assets and the ratio of current assets to current
liabilities, all of which we were in compliance with at the time of our repayment.

In the fourth quarter of 2020, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act. Through
October 31, 2022, we had repurchased 5.8 million shares at a cost of $68.3 million (an average price of $11.70 per share) under this authorization. All shares repurchased under the program have been retired. On
August 16, 2022, the Inflation Reduction Act (“IRA”) was enacted in the U.S. Among other provisions, the IRA included a one percent excise tax on corporate share repurchases. The one percent excise tax on share repurchases applies to shares
repurchased after December 31, 2022, and excludes repurchases under $1 million. We do not anticipate that the IRA will have a material effect on our financial performance.

In the first quarter of 2020, we acquired the remaining 0.2% of noncontrolling interests in Photronics Cheonan, Ltd. for $0.6 million.

In the first quarter of 2020, we adopted ASU 2016-02 and all subsequent amendments, collectively codified in Accounting Standards Codification Topic 842 - “Leases” (“Topic 842”). This guidance requires modified
retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption; we elected to apply the guidance at the beginning of the period of adoption, and recognized right-of-use leased
assets of approximately $6.5 million, and corresponding lease liabilities, which were discounted at our incremental borrowing rates, on our November 1, 2019, consolidated balance sheet to reflect our adoption of the guidance. Our adoption of
Topic 842 did not affect our cash flows or our ability to comply with covenants under our credit agreements.

24

Table of Contents

Results of Operations

The following tables present selected operating information expressed as a percentage of revenue. The columns may not foot due to rounding.

Three Months Ended
October 31, 2022July 31, 2022October 31, 2021
Revenue100.0%100.0%100.0%
Cost of goods sold61.861.971.3
Gross profit38.238.128.7
Selling, general and administrative expenses7.57.37.9
Research and development expenses1.91.92.3
Operating income28.829.018.5
Non-operating income (expense), net5.11.72.1
Income before income tax provision33.930.620.6
Income tax provision7.68.34.8
Net income26.322.415.8
Net income attributable to noncontrolling interests8.78.24.9
Net income attributable to Photronics, Inc. shareholders17.6%14.2%10.9%
Year Ended
October 31, 2022October 31, 2021October 31, 2020
Revenue100.0%100.0%100.0%
Cost of goods sold64.374.877.9
Gross profit35.725.222.1
Selling, general and administrative expenses7.88.78.8
Research and development expenses2.22.82.8
Other operating income, net0.00.5-
Operating income25.714.210.5
Non-operating income (expense), net3.31.1(0.4)
Income before income tax provision29.015.410.1
Income tax provision7.33.53.5
Net income21.711.96.6
Net income attributable to noncontrolling interests7.33.51.1
Net income attributable to Photronics, Inc. shareholders14.4%8.4%5.5%

Note: All the following tabular comparisons, unless otherwise indicated, are for the three months ended October 31, 2022 (Q4 FY22), July 31, 2022 (Q3 FY22) and October 31,
2021 (Q4 FY21), and for the fiscal years ended October 31, 2022 (FY22) and October 31, 2021 (FY21). Please refer to Part II, Item 7 of our 2021 Form 10-K for comparative discussion of our fiscal years ended October 31, 2021, and October 31,
2020. The tables in this item may not foot due to rounding.

25

Table of Contents

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first quarter of our fiscal
year by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

The following tables present changes in revenue disaggregated by product type and geographic origin, in Q4 FY22 and FY22 from revenue in prior reporting periods.

Quarterly Changes in Revenue by Product Type

Q4 FY22 compared to Q3 FY22Q4 FY22 compared to Q4 FY21
Revenue in Q4 FY22Increase (Decrease)Percent ChangeIncrease (Decrease)Percent Change
IC
High-end*$44.3$(8.3)(15.8)%$1.84.1%
Mainstream111.93.33.0%29.035.0%
Total IC$156.2$(5.0)(3.1)%$30.824.5%
FPD
High-end*$43.4$(7.3)(14.4)%$2.45.9%
Mainstream10.62.633.0%(4.2)(28.3)%
Total FPD$54.1$(4.6)(7.9)%$(1.8)(3.2)%
Total Revenue$210.3$(9.7)(4.4)%$29.016.0%

* High-end photomasks typically have higher ASPs than mainstream products.

Quarterly Changes in Revenue by Geographic Origin**

Q4 FY22 compared to Q3 FY22Q4 FY22 compared to Q4 FY21
Revenue in Q4 FY22Increase (Decrease)Percent ChangeIncrease (Decrease)Percent Change
Taiwan$76.3$(1.1)(1.4)%$7.110.3%
China52.4(8.1)(13.4)%14.136.7%
Korea38.00.10.2%0.20.4%
United States34.0(0.7)(1.9)%7.428.0%
Europe9.00.11.3%0.10.9%
Other0.50.02.3%0.121.9%
Total revenue$210.3$(9.7)(4.4)%$29.016.0%

** This table disaggregates revenue by the location in which it was earned.

Revenue in Q4 FY22 of $210.3 million represented a decrease of 4.4% compared with Q3 FY22, and an increase of 16.0% from Q4 FY21.

Overall IC revenue decreased 3.1% from Q3 FY22 due to lower high-end foundry and logic demand in Asia, but increased 24.5% from the prior year quarter. IC mainstream growth continued in Q4 FY22, increasing 3.0%
from Q3 FY22, and 35.0% from Q4 FY21, due to continued growth in demand and favorable pricing on photomasks used to produce semiconductors required to make or support consumer products, the “internet-of-things”, 5G wireless technology, and
cryptocurrency mining.

26

Table of Contents

FPD revenue decreased 7.9% and 3.2% in Q4 FY22, compared, respectively, with Q3 FY22 and Q4 FY21. The decreases were caused by weakened demand from Q322 for high-end large-area masks used for
mobile displays and G10.5+ masks used for ultra-large screen televisions. Revenue from mainstream products increased 33.0% from Q3 FY22, as capacity became available from the decreased demand for high-end products.

Year-over-Year Changes in Revenue by Product Type

FY22 compared to FY21
Revenue in FY22Increase (Decrease)Percent Change
IC
High-end*$195.3$32.419.9%
Mainstream397.7100.533.8%
Total IC$593.0$132.928.9%
FPD
High-end*$187.0$31.320.1%
Mainstream44.5(3.4)(7.1)%
Total FPD$231.5$27.913.7%
Total Revenue$824.5$160.824.2%

* High-end photomasks typically have higher ASPs than mainstream photomasks.

Year-over-Year Changes in Revenue by Geographic Origin**

FY22 compared to FY21
Revenue in FY22Increase (Decrease)Percent Change
Taiwan$291.3$42.717.2%
China212.696.983.7%
Korea156.1(0.3)(0.2)%
United States126.221.220.2%
Europe36.40.20.4%
Other1.90.14.9%
Total Revenue$824.5$160.824.2%

** This table disaggregates revenue by the location in which it was earned.

Revenue in YTD FY22 of $824.5 million surpassed our prior record revenue set in YTD FY21 by $160.8 million, or 24.2%. IC revenue increased by 28.9%, due to strong demand for
both high-end and mainstream photomasks and improved pricing for mainstream products and products at the most advanced node levels. FPD revenue increased by 13.7%, driven by a 20.1% increase in revenue from high-end products, which was driven
by increased demand and better pricing for AMOLED products used in mobile displays and increased demand for G10.5+ large area masks used for ultra-large televisions.

27

Table of Contents

Gross Margin

Percent Change
Q4 FY22Q3 FY22Q4 FY21Q4 FY22 from Q3 FY22Q4 FY22 from Q4 FY21
Gross profit$80.3$83.9$51.9(4.3)%54.5%
Gross margin38.2%38.1%28.7%

Gross margin was 38.2% for Q4 FY22, representing a slight increase from the Q3 FY22 gross margin of 38.1%, as decreased revenue of 4.4% was offset by decreased material costs which fell 7.7%, or 80
basis points as a percentage of revenue. Labor costs increased 5.2%, or 100 basis points as a percentage of revenue, due to increased costs in some locations. Equipment and other overhead costs decreased 5.3%, or 30 basis points as a percentage
of revenue, with lower outsourced manufacturing costs, partially offset by increased equipment maintenance costs, most significantly contributing to the net cost decrease.

Gross margin increased by 9.5 percentage points in Q4 FY22, from Q4 FY21, primarily as a result of the increase in revenue from the prior year quarter, together with 1.6% decrease in material costs
from the prior year quarter. Labor costs increased 21.8% from the prior year quarter, or 50 basis points as a percentage of revenue, primarily due to increased costs in some locations. Equipment and other overhead costs decreased 4.9%, or 580
basis points, as a percentage of revenue. Decreased depreciation expense and outsourced manufacturing costs, which were partially offset by increased equipment maintenance costs, were the primary contributors to the overall decrease.

FY22FY21Percent Change FY22 from FY21
Gross profit$294.2$167.076.1%
Gross margin35.7%25.2%

Gross margin increased by 10.5 percentage points in FY22, from FY21, primarily as a result of the increase in revenue from the prior year period, offset somewhat by the following net cost increases:
Material costs increased 7.9% from the prior year period, but decreased 380 basis points as a percentage of revenue. Labor costs increased 15.6% from the prior year, or 100 basis points as a percentage of revenue. Equipment and other overhead
costs increased by 2.7%, but decreased 580 basis points as a percentage of revenue, with increased outsourced manufacturing costs, which were partially offset by decreased depreciation expense, most significantly contributing to the overall
cost increase.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $15.7 million in Q4 FY22, compared with $16.0 million in Q3 FY22, and $14.3 million in Q4 FY21. The decrease from Q3 FY22 was
primarily the result of decreased compensation and related expenses of $0.5 million, and the increase from the prior year quarter was primarily the result of increased professional fees of $0.7 million and increased travel expenses of $0.3
million. Selling, general and administrative expenses increased $6.5 million to $64.0 million in FY22, from $57.5 million in FY21, primarily due to an increase in compensation and related expenses, professional
fees, and travel expenses in the respective amounts of $4.6 million, $0.7 million, and $0.6 million.

Research and Development Expenses

Research and development expenses, which primarily consist of development and qualification efforts related to process technologies for high-end IC and FPD applications, decreased $0.1 million to
$4.0 million in Q4 FY22, from Q3 FY22; the decrease was primarily caused by a decline in development activities in the U.S., which were partially offset by increased activities in Asia.  Research and development expenses in Q4 FY22 decreased by
$0.1 million in Q4 FY22 from Q4 FY21 as a result of decreased development activities in Asia moderately exceeding increased development activities in the U.S. On a year-to-date basis, research and development expenses decreased $0.1 million, to
$18.3 million, primarily due to decreased development activities in Asia exceeding increased activities in the U.S.

28

Table of Contents

Other Operating Income, Net

In the third quarter of 2021, we recorded a $3.5 million gain on the trade-in of a lithography tool with a tool vendor as partial compensation for a more advanced tool.

Non-Operating Income (Expense)

Q4 FY22Q3 FY22Q4 FY21
Foreign currency transactions impact, net$10.4$3.9$4.3
Interest expense, net(0.4)(0.6)(1.0)
Interest income and other income, net0.80.40.5
Total other income (expense)$10.8$3.6$3.8

Non-operating income (expense) increased in Q4 FY22 from Q3 FY22 by $7.2 million, and from Q4 FY21 by $7.0 million, primarily due to foreign currency impacts, driven by favorable movements of the
South Korean won, the New Taiwan dollar, and the Singapore dollar against the U.S. dollar offsetting unfavorable movements of the RMB against the U.S. dollar. In addition, higher average cash, cash equivalents, and short-term investments
balances in Q4 FY22 resulted in increased interest income compared to both prior comparative periods, and lower average interest-bearing debt balances resulted in lower interest expense, net of subsidies received in Q4 FY22, than was incurred
in the prior comparative periods.

FY22FY21
Foreign currency transactions impact, net$27.3$8.0
Interest expense, net(1.9)(1.7)
Interest income and other income, net1.71.2
Total other income (expense)$27.2$7.5

Non-operating income (expense) increased $19.7 million in full year FY22, compared with full year FY21, primarily due to foreign currency transactions, driven by favorable movements of the South
Korean won, the New Taiwan dollar, and the Singapore dollar offsetting unfavorable movements of the RMB against the U.S. dollar. In addition, higher average cash, cash equivalents, and short-term investments balances in FY22, compared with
FY21, resulted in increased interest income in the current year. Interest expense, net of subsidies increased in FY22, compared with FY21, due to receiving a lower amount of interest subsidies on our China-based debt in FY22, the effect of
which was partially mitigated by lower average interest-bearing debt balance in FY22 than in the prior year.

Income Tax Provision

Q4 FY22Q3 FY22Q4 FY21
Income tax provision$16.1$18.1$8.7
Effective income tax rate22.5%26.9%23.3%

The effective income tax rates are sensitive to the jurisdictional mix of our earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances where the tax
benefits of losses are not available.

The effective income tax rate decreased in Q4 FY22, compared with Q3 FY22, primarily due to changes in the period-to-period mix of jurisdictional earnings. The effective income tax rate decrease in Q4 FY22,
compared with Q4 FY21, is primarily due to the benefits of investment credits in certain non-U.S. jurisdictions in Q4 FY22, as well as changes in the jurisdictional mix of earnings.

29

Table of Contents

FY22FY21
Income tax provision$59.8$23.2
Effective income tax rate25.0%22.7%

The increase in the effective income tax rate on a full-year basis in FY22, compared with FY21, is primarily due to an increase of unremitted earnings tax and a decrease in credits in non-U.S. jurisdictions and the
release of a valuation allowance for a loss carryforward in a non-U.S. jurisdiction in FY21.

We consider all available evidence when evaluating the potential future realization of deferred tax assets, and when, based on the weight of all available evidence, we determine that it is more likely than not that
some portion or all of our deferred tax assets will not be realized, we reduce our deferred tax assets by a valuation allowance. We also regularly assess the potential outcomes of ongoing and future tax examinations and, accordingly, have
recorded accruals for such contingencies. Included in the balance of unrecognized tax benefits as of October 31, 2022 and October 31, 2021, are $5.6 million and $3.8 million respectively, recorded in Other
liabilities in the consolidated balance sheets that, if recognized, would impact the effective tax rates.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $18.2 million in Q4 FY22, compared with $18.0 million in Q3 FY22; the increase was the result of a net increase in the net incomes of our joint venture
operations. Net income attributable to noncontrolling interests increased by $9.4 million in Q4 FY22 from Q4 FY21, and by $37.1 million in FY22 from FY21, as a result of increased net income at both our Taiwan-based and China-based IC
facilities.

Liquidity and Capital Resources

Cash and cash equivalents was $319.7 million and $276.7 million as of October 31, 2022, and October 31, 2021, respectively. As of the most recent balance sheet date, total cash and cash equivalents included $299.7
million held by foreign subsidiaries. Net Cash, a non-GAAP financial measure as defined and discussed in the Non-GAAP Financial Measures section below, was $316.2 million and $165.0 million as of October 31, 2022, and October 31, 2021,
respectively. Our primary sources of liquidity are our cash on hand, cash we generate from operations, short-term investments, and borrowing capacity we have available from financial institutions. Our corporate credit agreement has a $50
million borrowing limit, with an expansion capacity to $100 million. Although we have not accessed funds under our corporate credit facilities since 2011, it continues to afford us financial flexibility. In addition, in China, we have
approximately $21.5 million of borrowing capacity to support local operations. See Note 6 to our condensed consolidated financial statements in Part II, Item 8 for additional information on our currently available financing.

We continually evaluate alternatives for efficiently funding our capital expenditures and ongoing operations. These reviews may result in our engagement in a variety of
investing and financing transactions, in the transfer of cash among subsidiaries, and/or the repatriation of cash to the U.S. The transfer of funds among subsidiaries could be subject to foreign withholding taxes; in certain jurisdictions,
repatriation of these funds to the U.S. may subject them to U.S. state income taxes and/or local country withholding taxes. We believe that our liquidity, including available financing, is sufficient to meet our
requirements through the next twelve months and thereafter for the foreseeable future. Through the utilization of our existing liquidity, cash we generate from operations, short-term investments, and (potentially) our borrowing capacity under
our financing arrangements, we plan to continue to invest in our business, with our investments targeted to align with our customers’ technology road maps. In addition, we stand ready to invest in mergers, acquisitions, or strategic
partnerships, should a suitable opportunity arise.

We estimate capital expenditures for our fiscal year 2023 will be approximately $130 million; these investments will be targeted towards high-end and mainstream point tools that will increase our operating capacity
and efficiency, and enable us to support our customers’ near-term demands. As of October 31, 2022, we had outstanding capital commitments of approximately $147.8 million and recognized liabilities related to
capital equipment purchases of approximately $5.3 million. Although payment timing could vary, primarily as a result of the timing of tool delivery, installation and testing, we currently estimate that we will fund $90.0 million of our total
$153.1 million committed and recognized obligations for capital expenditures over the next twelve months. Please refer to Notes 8 and 13 to our consolidated financial statements in Part II, Item 8 for additional information on our lease
liabilities and unrecognized commitments, respectively.

30

Table of Contents

In September 2020, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act. This authorization does not obligate the Company to repurchase any dollar amount or number of shares of common stock. As of October 31, 2022, there was approximately $31.7 million remaining under that authorization.
Depending on market conditions, we may utilize some or the entire remaining approved amount to reacquire additional shares. On August 16, 2022, the Inflation Reduction Act (“IRA”) was enacted in the U.S. Among
other provisions, the IRA included a one percent excise tax on corporate share repurchases. The one percent excise tax on share repurchases applies to shares repurchased after December 31, 2022, and excludes repurchases under $1 million. We
do not anticipate that the IRA will have a material effect on our liquidity.

As discussed in Note 4 of our consolidated financial statements in Part II, Item 8, DNP, the noncontrolling interest in our China-based joint venture has, under certain circumstances, the right to
put its interest in the joint venture to Photronics, or to purchase our interest in the joint venture. Under all such circumstances, the sale of DNP’s interest would be at its ownership percentage of the joint venture’s net book value, with
closing to take place within three business days of obtaining required approvals and clearance. As of the date of issuance of this report, DNP had not indicated its intention to exercise this right. As of October 31, 2022, Photronics and DNP
each had net investments in this joint venture of approximately $93.3 million.

Cash Flows

Year Ended
October 31, 2022October 31, 2021October 31, 2020
Net cash provided by operating activities$275.2$150.8$143.0
Net cash used in investing activities$(147.8)$(103.5)$(65.7)
Net cash used in financing activities$(38.7)$(53.9)$(16.0)

Operating Activities: Net cash provided by operating activities reflects net income adjusted for certain non-cash items, including depreciation and
amortization, share-based compensation, and the effects of changes in operating assets and liabilities. Net cash provided by operating activities increased by $124.4 million in FY22, compared with FY21, primarily due to increased net income
and net cash-favorable changes in working capital, predominantly in Asia.

Free Cash Flow, which is a non-GAAP financial measure as discussed in the “Non-GAAP Financial Measures” section below, increased by $119.0 million in FY22, compared with FY21, primarily due to increased net cash
provided by operating activities, and decreased by $30.0 million in FY21, compared with FY20, primarily due to an increase in spending on property, plant and equipment.

Investing Activities:  In FY22, net cash flows used in investing activities primarily consisted of purchases of $112.3 million of property, plant
and equipment. Net cash flows used in investing activities increased by $44.3 million in FY22, compared with FY21, primarily as a result of our investment of $38.9 million in short-term debt securities in FY22.

Financing Activities: In FY22, net cash flows used in financing activities primarily consisted of debt repayments of $65.4 million, which were
partially offset by contributions from noncontrolling interests of $25.0 million. Net cash used in financing activities decreased by $15.2 million in FY22, compared with FY21, primarily due to decreased share repurchases of $45.7 million and
an excess of the change in contributions from, as compared with distributions to, noncontrolling interests of $34.6 million, which were partially offset by increased debt repayments of $45.1 million (which included early repayments of $15.8
million), and decreased proceeds from long-term debt of $20.9 million.

Our cash, cash equivalents, and restricted cash balances were negatively impacted by changes in foreign currency exchange rates in FY22 by $46.0 million.

31

Table of Contents

Non-GAAP Financial Measures

We consider Free Cash Flow and Net Cash, which are “non-GAAP financial measures” (as such term is defined by the SEC), to be useful metrics in measuring our cash-generating performance. (Note that
we may define these terms differently than other companies that use similarly-named non-GAAP financial measures.) These non-GAAP metrics are not intended to represent funds available for our discretionary use or to be used as a substitute for Cash and cash equivalents or Net cash provided by operating activities, as measured under GAAP. The following tables reconcile Net
cash provided by operating activities to Free Cash Flow for FY22, FY21 and FY20. The columns may not foot due to rounding.

FY22FY21FY20
Free Cash Flow
Net cash provided by operating activities$275.2$150.8$143.0
Purchases of property, plant and equipment(112.3)(109.1)(70.8)
Government incentives3.65.85.3
Free cash flow$166.5$47.4$77.5

The following table reconciles Cash and cash equivalents to Net Cash at the balance sheet dates. The increase in Net Cash was primarily driven by an increase in Net

cash provided by operating activities, as discussed above. The columns may not foot due to rounding.

As of
October 31, 2022October 31, 2021
Net Cash
Cash, cash equivalents$319.7$276.7
Short-term investments38.9-
Current portion of Long-term debt(10.0)(22.2)
Long-term debt(32.3)(89.4)
Net cash$316.2$165.0

Business Outlook

Our current business outlook and guidance was provided in our Full Year and Fourth Quarter Fiscal 2022 Results earnings call, and related slide deck. These can be accessed in the investor section of our website -
www.photronics.com.

Our future results of operations and the other forward-looking statements contained in this filing and in our Full Year and Fourth Quarter Fiscal 2022 Results earnings call and presentation involve a number of
risks and uncertainties, some of which are discussed in Part I, Item 1A of this report. A number of other unforeseeable factors could cause actual results to differ materially from our expectations.

Critical Accounting Estimates

Our consolidated financial statements are based on the selection and application of accounting policies, which require management to make significant estimates and assumptions. We believe the following to be the
more critical areas that require judgment when applying our accounting policies:

Column 1Column 2Column 3
Revenue Recognition: The application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates, including the determination of whether we should recognize revenues as we perform or upon the completion of our performance, as these determinations impact the timing and amount of our reported revenues and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to recognize revenue, as well as the measurement of our progress towards satisfying our performance obligations, which determine the amount of revenue we are entitled to recognize.

32

Table of Contents

Column 1Column 2Column 3
Property, Plant and Equipment: Significant judgment and assumptions are employed when we establish the estimated useful lives of asset classes, and determine when depreciation should commence for individual assets, as these determinations can significantly impact our gross margin and research and development expenses. Significant judgement would also be employed when events or changes in circumstances indicate that the carrying amount of a group of assets may not be recoverable, as the recoverability assessment requires us to forecast future cash flows related to these assets; this evaluation can significantly impact our gross margin and operating expense.
Column 1Column 2Column 3
Leases: Significant judgement is applied in the determination of whether an arrangement is, or contains, a lease and, in certain instances, whether the lease should be classified as an operating lease or a finance lease, which can impact the timing and classification of lease costs.
Column 1Column 2Column 3
Contingencies: We are subject to the possibility of losses from various contingencies. Significant judgment is necessary to estimate the probability and amount of a loss, if any, from such contingencies. An accrual is made when it is probable that a liability has been incurred or an asset has been impaired and the amount of loss can be reasonably estimated. Changes in estimates related to, and resolutions of, contingencies may have a material impact on our financial performance.
Column 1Column 2Column 3
Income Taxes: Our annual tax rate is determined based on our income and the jurisdictions where it is earned, statutory tax rates, and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Also inherent in determining our annual tax rate are judgments and assumptions regarding the recoverability of certain deferred tax assets, and our ability to uphold certain tax positions. We are subject to complex tax laws, in the U.S. and numerous foreign jurisdictions, and the manner in which they apply can be open to interpretation. Realization of deferred tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction in future periods, which involves business plans, planning opportunities, and expectations about future outcomes. Our assessment relies on estimates and assumptions, and may involve a series of complex judgments about future events.

There are a number of estimates and assumptions inherent in calculating the various components of our tax provision. Future events such as changes in tax legislation, geographic mix of
earnings, findings in tax audits, and earnings repatriation plans could have an impact on those estimates and our effective tax rate.

Please refer to Notes 1, 11, and 13 to our consolidated financial statements in Part II, Item 8 for additional information related to these critical accounting estimates.

Effect of Recent Accounting Pronouncements

See Note 20 to our consolidated financial statements in Part II, Item 8 of this report for recent accounting pronouncements that may affect our financial reporting.

FY 2021 10-K MD&A

SEC filing source: 0001140361-21-042251.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2021-12-17. Report date: 2021-10-31.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

We sell substantially all of our photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance electronic
products such as photonics, micro-electronic mechanical systems, and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and display designs and applications,
particularly as they relate to the semiconductor industry's migration to more advanced product innovation, design methodologies, and fabrication processes. The demand for photomasks primarily depends on design activity rather than sales volumes
from products manufactured using photomask technologies. Consequently, an increase in semiconductor or display sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions
in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or display designs could reduce demand for photomasks ‒ even if the demand for
semiconductors and FPDs increases. Advances in semiconductor, display, and photomask design and production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks.
Historically, the microelectronic industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These negative trends have been characterized by, among other things, diminished product demand, excess production
capacity, and accelerated erosion of selling prices with a concomitant effect on revenue and profitability.

22

Table of Contents

We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC
photomasks and two to three weeks of backlog for FPD photomasks.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices,
mobile communications, and computing solutions. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we believe that
such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent
upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

We are focused on improving our competitiveness by advancing our technology and reducing costs and, in connection therewith, have invested and plan to continue to invest in manufacturing equipment to serve the high-end
markets. As we face challenges that require us to make significant improvements in our competitiveness, we continue to evaluate further cost reduction initiatives.

State-of-the-art production for semiconductor masks is considered to be 28 nanometer and smaller for ICs and Generation 10.5+ and AMOLED and LTPS display-based process technologies for FPDs. However, 32 nanometer and
above geometries for semiconductors and Generation 8 and below (excluding AMOLED and LTPS) process technologies for displays constitute the majority of designs currently being fabricated in volume. At these geometries, we can produce full lines of
photomasks, and there is no significant technology employed by our competitors that is not available to us. We expect advanced-generation designs to continue to move to production throughout fiscal 2022, and we believe we are well positioned to
service an increasing volume of this business as a result of our investments in manufacturing processes and technology in the regions where our customers are located.

The photomask industry has been, and is expected to continue to be characterized by technological change and evolving industry standards. In order to remain competitive, we will be required to continually anticipate,
respond to, and utilize changing technologies. In particular, we believe that, as semiconductor geometries continue to become smaller, and display designs become larger or otherwise more advanced, we will be required to manufacture even more
complex optically-enhanced reticles, including optical proximity correction and phase-shift photomasks. Additionally, demand for photomasks has been, and could, in the future be adversely affected by changes in high-performance electronics
fabrication methods that affect the type or quantity of photomasks used, such as changes in semiconductor demand that favor field-programmable gate arrays and other semiconductor designs that replace application-specific ICs, or the use of certain
chip-stacking methodologies that lessen the emphasis on conventional lithography technology. Furthermore, increased market acceptance of alternative methods of transferring circuit designs onto semiconductor wafers could reduce or eliminate the
need for photomasks in the production of semiconductors. As of the end of 2021, one alternative method, direct-write lithography, has not been proven to be a commercially viable alternative to photomasks, as it is considered to be too slow for
high-volume semiconductor wafer production, and we have not experienced a significant loss of revenue as a result of this or other alternative semiconductor design methodologies. However, should direct-write lithography or any other alternative
method of transferring IC designs to semiconductor wafers without the use of photomasks achieve market acceptance, and we do not anticipate, respond to, or utilize these or other changing technologies due to resource, technological, or other
constraints, our business and results of operations could be materially adversely affected.

Both our revenues and costs have been affected by the increased demand for high-end-technology photomasks that require more advanced manufacturing capabilities, but generally command higher ASPs. Our capital
expenditure payments were $109.1 million, $70.8 million and $178.3 million in 2021, 2020 and 2019, respectively, and the depreciation on these purchases has significantly contributed to our cost of goods sold. We intend to continue to make the
required investments to support the technological demands of our customers that we believe will position the Company for future growth. In support of this effort, we expect capital expenditure payments to be approximately $100 million in fiscal
year 2022.

23

Table of Contents

The manufacture of photomasks for use in fabricating ICs, FPDs, and other related products built using comparable photomask-based process technologies has been, and continues to be, capital intensive. Our employees and
our integrated global manufacturing network represent a significant portion of our fixed operating cost base. Should our revenue decrease as a result of a decrease in design releases from our customers, we may have excess or underutilized
production capacity, which could significantly impact our operating margins, or result in write-offs from asset impairments.

Recent Developments

In the second quarter of 2021, under an MLA which we entered into effective October 2020, we entered into a five-year $7.2 million finance lease for a high-end inspection tool. Monthly payments on the lease, which
commenced in February 2021, are $0.1 million per month. Upon the payment of the fiftieth monthly payment and prior to payment of the fifty-first monthly payment, we may exercise an early buyout option to purchase the tool for $2.4 million. If we do
not exercise the early buyout option, then at the end of the five-year lease term, the lease shall continue to renew on a month-to-month basis at the same rental terms; at our option, after the original term or any renewal periods, we may return
the tool, elect to extend the lease, or purchase the tool at its fair market value. Since we are reasonably certain that we will exercise the early buyout option, our lease liability reflects such exercise and we have classified the lease as a
finance lease. The interest rate implicit in the lease is 1.08%.

In the first quarter of 2021, under an MLA which we entered into effective July 2019, we entered into a five-year $35.5 million finance lease for a high-end lithography tool. Monthly payments on the lease, which
commenced in January 2021, increased from $0.04 million after the first three months to $0.6 million for the following nine months, to be followed by forty-eight monthly payments of $0.5 million. As of the due date of the forty-eighth monthly
payment, we may exercise an early buyout option to purchase the tool for $14.1 million. If we do not exercise the early buyout option, then at the end of the five-year lease term, at our option, we may return the tool, elect to extend the lease
term for a period and a lease payment to be agreed with lessor at the time, or purchase the tool for its then-fair market value as determined by the lessor. Since we are reasonably certain that we will exercise the early buyout option, our lease
liability reflects such exercise and we have classified the lease as a finance lease. The interest rate implicit in the lease is 1.58%. The lease agreement incorporates the covenants included in our Corporate Credit Agreement, which are detailed in
Note 9 of Part II, Item 8 of this report, and includes a cross-default provision for any agreement or instrument with an outstanding, committed balance greater than $5.0 million in which we are the indebted party.

In the fourth quarter of 2020, we entered into a MLA with a financing entity for the lease of an inspection tool with a maximum value of $10 million.  The tool was delivered during the fourth
quarter of 2020, and the financing entity made a progress payment to the vendor of $6.5 million in the first quarter of 2021. The progress payment accrued interest at 1.56% payable monthly until the final payment for the tool was made in the second
quarter of 2021, at which point the $7.2 million lease described above began.

In the fourth quarter of 2020, our Hefei, China, facility was approved to borrow 200 million RMB (approximately $31.3 million, at the balance sheet date) from the China Construction Bank Corporation. This credit
facility is subject to annual reviews and extension, with the most recent extension allowing us to borrow additional funds set to expire in August 2022. The loan proceeds were used to fund purchases of two lithography tools at the Hefei facility.
As of October 31, 2021, we had borrowed 135.7 million RMB ($21.2 million) against this approval (all of which was then outstanding), and 64.3 million RMB ($10.1 million) remained available to borrow. The interest rate on the loan is variable and
based on the RMB Loan Prime Rate of the National Interbank Funding Center. The borrowings are secured by the Hefei facility, its related land use right, and certain manufacturing equipment. The Hefei Equipment Loan is subject to covenants and
provisions, certain of which relate to the assets pledged as security for the loan, including covenants for the ratio of total liabilities to total assets and the ratio of current assets to current liabilities, all of which we were in compliance
with at October 31, 2021.

24

Table of Contents

In the fourth quarter of 2020, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act. Through
October 31, 2021, we had repurchased 5.6 million shares at a cost of $65.7 million (an average price of $11.64 per share) under this authorization. All shares repurchased in 2020 were retired in 2020, and all shares repurchased in 2021 were retired
in 2021.

In the first quarter of 2020, we acquired the remaining 0.2% of noncontrolling interests in Photronics Cheonan, Ltd. for $0.6 million.

In the first quarter of 2020, we adopted ASU 2016-02 and all subsequent amendments, collectively codified in Accounting Standards Codification Topic 842 - “Leases” (“Topic 842”). This guidance requires modified
retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption; we elected to apply the guidance at the beginning of the period of adoption, and recognized right-of-use leased assets
of approximately $6.5 million, and corresponding lease liabilities, which were discounted at our incremental borrowing rates, on our November 1, 2019, consolidated balance sheet to reflect our adoption of the guidance. Our adoption of Topic 842 did
not affect our cash flows or our ability to comply with covenants under our credit agreements.

In the fourth quarter of 2019, our board of directors declared a dividend of one preferred stock purchase right (a “Right”), payable on or about October 1, 2019, for each share of common stock,
par value $0.01 per share, of the Company outstanding on September 30, 2019, to the stockholders of record on that date. In connection with the distribution of the Rights, we entered into a Section 382 Rights Agreement (the “Rights Agreement”),
dated as of September 23, 2019, between the Company and Computershare Trust Company, N.A., a federally chartered trust company, as rights agent. The purpose of the Rights Agreement is to deter trading of our common stock that would result in a
change in control (as defined in Internal Revenue Control Section 382), thereby preserving our future ability to use our historical federal net operating losses and other Tax Attributes (as defined in the Rights Agreement). Each Right entitles
the registered holder to purchase from the Company one one-thousandth of a share of Series A Preferred Stock, par value $0.01 per share, at a price of $33.63, subject to adjustment. The Rights, which are described in the Company’s Current Report
on Form 8-K filed on September 24, 2019, are in all respects subject to and governed by the provisions of the Rights Agreement. The Rights will expire at the earliest to occur of (i) the date on which our board of directors determines, in its
sole discretion, that the Rights Agreement is no longer necessary for the preservation of material valuable tax attributes, or the tax attributes have been fully utilized and may no longer be carried forward, and (ii) the close of business on
September 22, 2022.

In the fourth quarter of 2019, upon our request, a financing entity made an advance payment of $3.5 million to an equipment vendor. We entered into an MLA with this financing entity, which became
effective in July 2019. The MLA enabled us to request advance payments or other funds to finance equipment to be leased or purchased in the U.S. In connection with this MLA, we had been approved for financing of $35 million for the purchase of a
high-end lithography tool. Interest on this borrowing was variable and payable monthly at thirty-day LIBOR plus 1% and was to continue to accrue until the borrowing was repaid or, as allowed under the MLA, we entered into a lease for the equipment.
During the first quarter of 2021, this financing entity made an additional payment of $28 million to the equipment vendor on our behalf and we subsequently entered into the $35.5 million finance lease described above.

In the fourth quarter of 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as
amended). We repurchased 2.5 million shares at a cost of $27.9 million (an average price of $11.34 per share) under this authorization. The repurchase program was terminated on March 20, 2020.

In the second quarter of 2019, we repaid, upon maturity, the entire $57.5 million principal amount of the convertible senior notes we issued in April 2016.

25

Table of Contents

In the first quarter of 2019, PDMCX obtained approval to borrow 345.0 million RMB from the Industrial and Commercial Bank of China. From November 2018 through July 2020, PDMCX entered into separate loan agreements (the
“Project Loans”) for the entire approved amount and, as of October 31, 2021, 255.0 million RMB ($39.9 million) remained outstanding. The Project Loans were used to finance certain capital expenditures at the PDMCX facility, and are collateralized
by liens granted on the land use right, building, and certain equipment located at the facility. The interest rates on the Project Loans are variable (based on the RMB Loan Prime Rate of the National Interbank Funding Center), and interest incurred
on the loans is eligible for reimbursement through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide for such reimbursements up to a prescribed limit and duration. The Project Loans are subject to covenants
and provisions, certain of which relate to the assets pledged as security for the loans, all of which we were in compliance with at October 31, 2021.

In the first quarter of 2019, PDMCX obtained approval for revolving, unsecured credit of the equivalent of $25.0 million, pursuant to which PDMCX may enter into separate loan agreements with varying terms to maturity.
This facility is subject to annual reviews and extension. Unless extended, this facility will expire in October 2022. As of October 31, 2021, PDMCX had 78.0 million RMB ($12.2 million) outstanding against the approval. The interest rates are
variable, based on the RMB Loan Prime Rate of the National Interbank Funding Center. Interest incurred on the loans are eligible for reimbursement through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide
for such reimbursements up to a prescribed limit and duration.

26

Table of Contents

Results of Operations

The following tables present selected operating information expressed as a percentage of revenue. The columns may not foot due to rounding.

Three Months Ended
October 31, 2021August 1, 2021October 31, 2020
Revenue100.0%100.0%100.0%
Cost of goods sold71.373.478.6
Gross profit28.726.621.4
Selling, general and administrative expenses7.98.88.6
Research and development expenses2.33.12.8
Other operating income, net-2.1-
Operating income18.516.710.0
Non-operating income (expense), net2.12.2(1.9)
Income before income tax provision20.618.98.1
Income tax provision4.84.62.3
Net income15.814.35.8
Net income attributable to noncontrolling interests4.94.31.5
Net income attributable to Photronics, Inc. shareholders10.9%10.0%4.3%
Year Ended
October 31, 2021October 31, 2020October 31, 2019
Revenue100.0%100.0%100.0%
Cost of goods sold74.877.978.1
Gross profit25.222.121.9
Selling, general and administrative expenses8.78.89.5
Research and development expenses2.82.82.9
Other operating income, net0.5--
Operating income14.210.59.5
Non-operating income (expense), net1.1(0.4)(0.3)
Income before income tax provision15.410.19.2
Income tax provision3.53.51.9
Net income11.96.67.3
Net income attributable to noncontrolling interests3.51.11.9
Net income attributable to Photronics, Inc. shareholders8.4%5.5%5.4%

Note: All the following
tabular comparisons, unless otherwise indicated, are for the three months ended October 31, 2021 (Q4 FY21), August 1, 2021 (Q3 FY21) and October 31, 2020 (Q4 FY20), and for the fiscal years ended October 31, 2021 (FY21) and October 31, 2020
(FY20). Please refer to the MD&A in our 2020 Annual Report on Form 10-K for comparative discussion of our fiscal years ended October 31, 2020, and October
31, 2019. Table columns may not foot due to rounding.

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first quarter of our fiscal year
by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

27

Table of Contents

At the beginning of 2020, we changed the threshold for the definition of high-end FPD, from G8 and above and AMOLED display screens, to G10.5+, AMOLED, and LTPS display screens, to reflect the overall advancement of technology in the FPD industry. Our definition of high-end IC products remained as 28 nanometer or smaller. High-end photomasks typically have
higher ASPs than mainstream products.

The following tables present changes in revenue disaggregated by product type and geographic origin, in Q4 FY21 and FY21 from revenue in prior reporting periods.

Quarterly Changes in Revenue by Product Type

Q4 FY21 from Q3 FY21Q4 FY21 from Q4 FY20
Revenue in Q4 FY21Increase (Decrease)Percent ChangeIncrease (Decrease)Percent Change
IC
High-end*$42.6$0.20.5%$4.411.6%
Mainstream82.97.49.9%15.122.3%
Total IC$125.4$7.76.5%$19.518.4%
FPD
High-end*$41.0$0.30.8%$9.730.9%
Mainstream14.92.621.5%2.823.2%
Total FPD$55.8$3.05.6%$12.528.8%
Total Revenue$181.3$10.66.2%$32.021.4%

* High-end photomasks typically have higher ASPs than mainstream products.

Quarterly Changes in Revenue by Geographic Origin**

Q4 FY21 from Q3 FY21Q4 FY21 from Q4 FY20
Revenue in Q4 FY21Increase (Decrease)Percent ChangeIncrease (Decrease)Percent Change
Taiwan$69.2$5.38.3%$12.522.1%
Korea37.8(1.8)(4.5)%1.23.4%
China38.35.717.4%17.382.6%
United States26.61.97.6%(0.1)(0.4)%
Europe9.0(0.5)(4.9)%1.013.0%
Other0.40.05.4%0.0(4.6)%
Total revenue$181.3$10.66.2%$32.021.4%

** This table disaggregates revenue by the location in which it was earned.

Revenue in Q4 FY21 of $181.3 million increased 6.2% compared with Q3 FY21 and 21.4% from Q4 FY20; on a year-to-date basis, revenue increased 8.9% in FY21, compared with FY20, to $663.8 million.

A 6.5% increase in IC revenue in Q4 FY21, compared with Q3 FY21, was primarily the result of strong demand for mainstream masks, particularly at the most advanced levels. Industry-wide capacity
constraints led to improved pricing for both high-end and mainstream products that resulted in IC revenue increasing 18.4% in Q4 FY21, compared with Q4 FY20. Increased demand from logic customers and Asia-based foundries were the sources of the
increase, while demand for memory masks remained stable.

28

Table of Contents

FPD revenue increased 5.6% in Q4 FY21, compared with Q3 FY21, and 28.8% in Q4 FY21, compared with Q4 FY20. The increase from Q3 FY21 was primarily the result of increased demand attributable to
new design releases of mainstream photomasks for liquid crystal displays (“LCD”), as panel manufacturers began to shift to introducing new designs to maintain or increase market share. This trend, and an increase in demand for AMOLED photomasks
for displays used in mobile applications, were the primary drivers of the increase from the prior year quarter.

Year-over-Year Changes in Revenue by Product Type

FY21 from FY20
Revenue in FY21Increase (Decrease)Percent Change
IC
High-end*$163.0$6.84.4%
Mainstream297.234.913.3%
Total IC$460.2$41.810.0%
FPD
High-end*$155.7$16.111.5%
Mainstream47.9(3.8)(7.4)%
Total FPD$203.6$12.36.4%
Total Revenue$663.8$54.18.9%

* High-end photomasks typically have higher ASPs than mainstream photomasks.

Year-over-Year Changes in Revenue by Geographic Origin**

FY21 from FY20
Revenue in FY21Increase (Decrease)Percent Change
Taiwan$248.6$9.54.0%
Korea156.43.32.2%
China115.736.445.8%
United States105.00.10.1%
Europe36.24.715.0%
Other1.80.13.6%
Total Revenue$663.8$54.18.9%

** This table disaggregates revenue by the location in which it was earned.

Revenue increased 8.9% in YTD FY21, compared with YTD FY20, to $663.8 million. IC revenue increased 10.0%, due to both
improved pricing for mainstream photomasks, and improved pricing and increased demand for high-end masks at the largest node levels. We believe that the increased demand for high-end photomasks at the largest node levels may be indicative of a
trend towards chipmakers differentiating their products through the design of application specific integrated circuits (“ASIC”), in lieu of migrating to smaller tech-node photomasks. FPD revenue increased 6.4% from YTD FY20, due to both
increased demand and improved pricing for AMOLED photomasks and, to a lesser extent, LTPS photomasks.

29

Table of Contents

Gross Margin

Percent Change
Q4 FY21Q3 FY21Q4 FY20Q4 FY21 from Q3 FY21Q4 FY21 from Q4 FY20
Gross profit$51.9$45.3$31.914.6%62.9%
Gross margin28.7%26.6%21.4%

Gross margin increased by 2.1 percentage points in Q4 FY21, from Q3 FY21, primarily as a result of the increase in revenue from the prior quarter. Material costs increased 3.4% from the prior
quarter, but decreased, as a percentage of revenue, by 80 basis points. Labor costs decreased 0.3% and fell 70 basis points, as a percentage of revenue. Equipment and other overhead costs increased 4.3%, but decreased 60 basis points as a
percentage of revenue, with higher outsourced manufacturing costs, partially offset by decreased equipment maintenance costs, most significantly contributing to the net cost increase.

Gross margin increased by 7.3 percentage points in Q4 FY21, from Q4 FY20, primarily as a result of the increase in revenue from the prior year quarter. Material costs increased 14.7% from the
prior year quarter, but decreased 160 basis points, as a percentage of revenue. Labor costs increased 10.9% from the prior year quarter, but fell 100 basis points as a percent of revenue, while equipment and other overhead costs rose 6.3%, but
fell 460 basis points, as a percentage of revenue. Increased outsourced manufacturing costs and equipment service contract costs were the most significant contributors to the rise in equipment and other overhead costs.

FY21FY20Percent Change FY21 from FY20
Gross profit$167.0$134.724.1%
Gross margin25.2%22.1%

Gross margin increased by 3.1 percentage points in YTD FY21, from YTD FY20, primarily as a result of the increase in revenue from the prior year period. Material costs increased 6.2% from the
prior year period, but decreased 70 basis points as a percentage of revenue. Labor costs increased 10.7% from the prior year, but rose only 10 basis points when compared to revenue. Equipment and other overhead costs increased by 1.2%, but
decreased 250 basis points as a percentage of revenue, with increased equipment service contract costs most significantly contributing to the overall cost increase.

As we operate in a high fixed cost environment, increases or decreases in our revenues and capacity utilization will generally positively or negatively impact our gross margin.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $14.3 million in Q4 FY21, compared with $15.1 million in Q3 FY21, and $12.8 million in Q4 FY20. The decrease from Q3 FY21 was primarily the result of decreased professional fees of $0.3 million and compensation and related expenses of $0.2 million, and the increase from the prior year quarter was primarily the
result of increased compensation and related expenses of $1.7 million and increased export duties (primarily incurred in Asia) of $0.2 million; these increases were partially offset by decreased professional fees of $0.9 million. Selling, general and administrative expenses increased $3.9 million, or 7.4%, in YTD FY21, from YTD FY20, primarily due to an increase in compensation and related expenses of $3.9 million.

30

Table of Contents

Research and Development Expenses

Research and development expenses, which primarily consist of development and qualification efforts related to high-end process
technologies for high-end IC and FPD applications, were $4.1 million in Q4 FY21, compared with $5.3 million in Q3 FY21; the decrease was primarily caused by a decline in development activities in the U.S.  Research and development expenses in
Q4 FY21 were unchanged from Q4 FY20. On a year-to-date basis, research and development expenses increased $1.3 million, primarily due to increased development
activities in the U.S. exceeding a decline in such activities at our China-based FPD facility.

Other Operating Income, Net

In the third quarter of 2021, we recorded a $3.5 million gain on the trade-in of a lithography tool with a tool vendor as partial compensation for a more advanced tool.

Non-Operating Income (Expense)

Q4 FY21Q3 FY21Q4 FY20
Foreign currency transactions impact, net$4.3$4.3$(2.2)
Interest expense, net(1.0)(1.1)(0.8)
Interest income and other income, net0.50.50.1
Total other income (expense)$3.8$3.7$(2.9)

Non-operating income and expense was essentially unchanged in Q4 FY21 from Q3 FY21, primarily due to favorable movements of the RMB against the U.S. dollar offsetting unfavorable
movements of the South Korean won against the U.S. dollar, and interest expense, net decreasing due to our reduced loan and finance lease balances. Non-operating income and expense changed favorably from a loss of $2.9 million in Q4 FY20 to
income of $3.8 million in Q4 FY21. The $6.7 million favorable change was primarily due to favorable movements of the New Taiwan dollar and the South Korean won against the U.S. dollar, which were partially offset by unfavorable movements of the
RMB against the U.S. dollar.

FY21FY20
Foreign currency transactions impact, net$8.0$(0.5)
Interest expense, net(1.7)(2.4)
Interest income and other income, net1.20.5
Total other income (expense)$7.5$(2.3)

Non-operating income and expense increased $9.8 million in YTD FY21, compared with YTD FY20, primarily due to favorable movements of the South Korean won and the RMB against the
U.S. dollar. Interest expense, net decreased year over year, due to a lower weighted-average interest rate on our debt, which offset a year over year increase in our average debt balance.

Income Tax Provision

Q4 FY21Q3 FY21Q4 FY20
Income tax provision$8.7$7.8$3.5
Effective income tax rate23.3%24.4%28.8%

The effective income tax rates are sensitive to the jurisdictional mix of our earnings, due, in part, to the non-recognition of tax provisions and benefits on losses in jurisdictions with valuation allowances.

31

Table of Contents

The effective income tax rate decreased slightly in Q4 FY21, compared with Q3 FY21, primarily due to changes in the period-to-period
mix of jurisdictional earnings. The effective income tax rate decrease in Q4 FY21, compared with Q4 FY20, is primarily due to the benefits of investment credits in certain non-U.S. jurisdictions in Q4 FY21, as well as changes in the jurisdictional mix of earnings.

FY21FY20
Income tax provision$23.2$21.3
Effective income tax rate22.7%34.5%

The decrease in the effective income tax rate on a full-year basis in FY21, compared with FY20, is primarily due to the establishment of a valuation allowance for a loss carryforward in a non-U.S. jurisdiction in
YTD-FY20, as well as changes in the jurisdictional mix of earnings.

We consider all available evidence when evaluating the potential future realization of deferred tax assets, and when, based on the weight of all available evidence, we determine that it is more likely than not that
some portion or all of our deferred tax assets will not be realized, we reduce our deferred tax assets by a valuation allowance. We also regularly assess the potential outcomes of ongoing and future tax examinations and, accordingly, have
recorded accruals for such contingencies. Included in the balance of unrecognized tax benefits as of October 31, 2021 and October 31, 2020, are $3.8 million and $2.0 million respectively, recorded in Other
liabilities in the consolidated balance sheets that, if recognized, would impact the effective tax rates.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $8.8 million in Q4 FY21, compared with $7.3 million in Q3 FY21, and $2.1 million in Q4 FY20. On a year-to-date basis, net income attributable to noncontrolling
interests increased $16.8 million from $6.5 million in YTD FY20 to $23.4 million in YTD FY21. All of these increases resulted from improved net income at both our Taiwan-based and China-based IC facilities.

Liquidity and Capital Resources

Cash and cash equivalents totaled $276.7 million and $278.7 million as of October 31, 2021 and October 31, 2020, respectively. As of the most recent balance sheet date, total cash and cash equivalents included $216.5
million held by foreign subsidiaries. Our primary sources of liquidity are our cash on hand, cash we generate from operations, and borrowing capacity we have available from financial institutions. Our
corporate credit agreement has a $50 million borrowing limit, with an expansion capacity to $100 million. Although we have not accessed funds under our corporate credit facility since 2011, it continues to afford us financial flexibility. In
addition, in China, we currently have approximately $22.9 million of borrowing capacity to support local operations. Please refer to Note 7 to the consolidated financial statements for additional information on our current borrowing capacity.

We continually evaluate alternatives for efficiently funding our capital expenditures and ongoing operations. These reviews may result in our engagement in a variety of financing transactions, in the transfer of cash among subsidiaries, and/or the repatriation of cash to the U.S. The transfer of funds among subsidiaries could be subject to
foreign withholding taxes; in certain jurisdictions, repatriation of these funds to the U.S. may subject them to U.S. state income taxes and/or local country withholding taxes. We believe that our liquidity,
including available financing, is sufficient to meet our requirements through the next twelve months and thereafter for the foreseeable future. Through the utilization of our existing liquidity, cash we generate from operations, and
(potentially) our borrowing capacity under our financing arrangements, we plan to continue to invest in our business, with our investments targeted to align with our customers’ technology road maps. In addition, we stand ready to invest in
mergers, acquisitions, or strategic partnerships, should the right opportunity be available.

We estimate capital expenditures for our fiscal year 2022 will be approximately $100 million; these investments will be targeted towards high-end and
mainstream point tools that will increase our operating capacity and efficiency, and enable us to support our customers’ near-term demands. As of
October 31, 2021, we had outstanding capital commitments of approximately $73.7 million and recognized liabilities related to capital equipment purchases of approximately $9.7 million. Although payment timing could vary, primarily as a result
of the timing of tool installation and testing, we currently estimate that we will fund $61.4 million of our total $83.4 million committed and recognized obligations for capital expenditures over the next twelve months. Please refer to Notes
9 and 14 to our consolidated financial statements for additional information on our lease liabilities and unrecognized commitments, respectively.

32

Table of Contents

In September 2020, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act. This authorization does not obligate the Company to repurchase any dollar amount or number of shares of common stock. As of October 31, 2021, there was approximately $34.3 million remaining under that authorization.
Depending on market conditions, we may utilize some or the entire remaining approved amount to reacquire additional shares.

Cash Flows

Year Ended
October 31, 2021October 31, 2020October 31, 2019
Net cash provided by operating activities$150.8$143.0$68.4
Net cash used in investing activities$(103.5)$(65.7)$(151.4)
Net cash used in financing activities$(53.9)$(16.0)$(42.1)

Operating Activities: Net cash provided by operating activities reflects net
income adjusted for certain non-cash items, including depreciation and amortization, share-based compensation, and the effects of changes in operating assets and liabilities. Net cash provided by operating activities increased by $7.7 million
in 2021, compared with 2020, due to increased net income and share based compensation, partially offset by lower depreciation and other noncash adjustments and net changes in working capital, predominantly in Asia.

Investing Activities:  Net cash flows used in investing activities primarily
consisted of purchases of property, plant and equipment. Purchases of property, plant and equipment were $109.1 million in 2021, compared with $70.8 million in 2020, as we increased our tool purchases in the current year, primarily in
response to market demands in Asia.

Financing Activities: Net cash flows used in financing activities primarily
consist of share repurchases, proceeds from and repayments of debt, and contributions from and distributions to noncontrolling interests. Net cash used in financing activities increased by $37.9 million in 2021, compared with 2020, due to
increased share repurchases of $13.9 million, an excess of the change in distributions to, as compared with contributions from, noncontrolling interests of $11.0 million, and increased debt repayments of $13.0 million.

In January 2018, Photronics, through its wholly owned Singapore subsidiary, and DNP, through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” entered into a joint venture under which DNP
obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture, which we refer to as PDMCX, was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. Under the joint
venture’s operating agreement, DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that may arise after the initial
two-year term of the operating agreement that cannot be resolved between the two parties. As of the date of issuance of this report, DNP had not indicated its intention to exercise this right. In addition, both Photronics and DNP have the option
to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below 20% for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the
exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. Should DNP exercise an option to put their, or purchase our, interest
in PDMCX we may, depending on the relationship of the fair and book value of PDMCX’s net assets, incur a loss. As of October 31, 2021, Photronics and DNP each had net investments in PDMCX of approximately $64.0 million.

33

Table of Contents

Business Outlook

Our current business outlook and guidance was provided in our Full Year and Fourth Quarter Fiscal 2021 Results earnings call, and related slide deck. These can be
accessed in the investor section of our website - www.photronics.com.

Our future results of operations and the other forward-looking statements contained in this filing and in our Full Year and Fourth Quarter Fiscal 2021 Results earnings call and presentation involve a number of risks
and uncertainties, some of which are discussed in Part I, Item 1A of this report. A number of other unforeseeable factors could cause actual results to differ materially from our expectations.

Critical Accounting Estimates

Our consolidated financial statements are based on the selection and application of accounting policies, which require management to make significant estimates and assumptions. We believe the following to be the more
critical areas that require judgment when applying our accounting policies:

Column 1Column 2Column 3
Revenue Recognition: Application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates. Specifically, the determination of whether revenues related to our revenue contracts should be recognized over time or at a point in time, as these determinations impact the timing and amount of our reported revenues and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to receive payment, as well as the progress of the job order to completion in order to determine the amount of arrangement consideration earned for contractual revenue recognized over time.
Column 1Column 2Column 3
Property, Plant and Equipment: Significant judgment and assumptions are employed when we establish estimated useful lives, depreciation periods and when depreciation should begin on such assets as this evaluation can significantly impact our gross margin and research and development expenses. Significant judgement is also required when we periodically review property, plant and equipment for any potential impairment in carrying values, whenever events such as a significant industry downturn, plant closures, technological obsolescence, or other change in circumstances indicate that their carrying amounts may not be recoverable as the recoverability assessment requires us to forecast future cash flows related to these assets; this evaluation can significantly impact our gross margin and operating expense.
Column 1Column 2Column 3
Leases: Significant judgement is applied in the determination of whether an arrangement is, or contains, a lease and, in certain instances, whether the lease should be classified as an operating lease or a finance lease, which can impact the timing and classification of lease costs.
Column 1Column 2Column 3
Contingencies: We are subject to the possibility of losses from various contingencies. Significant judgment is necessary to estimate the probability and amount of a loss, if any, from such contingencies. An accrual is made when it is probable that a liability has been incurred or an asset has been impaired and the amount of loss can be reasonably estimated. In accounting for the resolution of contingencies, significant judgment may be necessary to estimate amounts pertaining to periods prior to the resolution that are charged to operations in the period of resolution and amounts related to future periods.
Column 1Column 2Column 3
Income Taxes: Our annual tax rate is determined based on our income and the jurisdictions where it is earned, statutory tax rates, and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Also inherent in determining our annual tax rate are judgments and assumptions regarding the recoverability of certain deferred tax balances, and our ability to uphold certain tax positions. We are subject to complex tax laws, in the U.S. and numerous foreign jurisdictions, and the manner in which they apply can be open to interpretation. Realization of deferred tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction in future periods, which involves business plans, planning opportunities, and expectations about future outcomes. Our assessment relies on estimates and assumptions, and may involve a series of complex judgments about future events.

34

Table of Contents

There are a number of estimates and assumptions inherent in calculating the various components of our tax provision. Future events such as changes in tax legislation,
geographic mix of earnings, completion of tax audits or earnings repatriation plans could have an impact on those estimates and our effective tax rate.

Please refer to Notes 3, 8, 9, 12 and 14 to our consolidated financial statements in Part II, Item 8 for additional information related to these critical accounting estimates and our other significant accounting
policies.

Effect of Recent Accounting Pronouncements

See “Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Note 21 Recent Accounting Pronouncements” for recent accounting pronouncements that may affect our financial
reporting.